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ABSTRACT 
DEFINING THE DIFFICULT-TO-SEDATE CLINICAL PHENOTYPE  
IN CRITICALLY ILL CHILDREN 
Ruth M. Lebet 
Martha A. Q. Curley, PhD, RN 
Each year thousands of critically-ill children receive sedation to help them 
tolerate intensive care therapies.  A significant number of these children do not 
respond as expected to appropriately dosed sedation and remain agitated for 
some period, leading to iatrogenic injury and increased stress, as well as 
increased resource use. Children who remain under-sedated despite optimal 
therapy are considered “difficult-to-sedate”, but, to date, little data have been 
available to support an accurate description of this group of children. Recent 
attention to heterogeneity of treatment effect has spurred the development of 
clinical phenotypes that describe subgroups of patients within a disease process 
who differ in their clinical attributes and responses to therapy. Defining the 
difficult-to-sedate clinical phenotype in critically ill children is important because it 
will allow the use of sedation therapy targeted to the unique clinical, 
physiological, and developmental characteristics of the child.  
The three papers developed in this dissertation study explored the concept of the 
difficult-to-sedate child clinical phenotype.  A comprehensive review of the 
literature identified the lack of an operational definition and identified factors 
contributing to the clinical phenotype.  These factors were used to develop an 
initial operational definition and to construct a conceptual model. Expert critical 
care clinicians validated the elements of the operational definition through an 
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assessment of face and content validity and proposed additional factors for 
inclusion in the model. A refined definition was tested using data from the 
RESTORE study.  Characteristics identified through latent class and 
classification and regression tree analysis were consistent with the conceptual 
model proposed.   
Decreasing the ambiguity that currently exists around the concept of the difficult-
to-sedate child clinical phenotype is a major achievement of this study.  A clear 
operational definition of the concept promotes its consistent measurement and 
facilitates future investigation, and allows useful comparisons across studies.  
The conceptual model and operational definition require further investigation and 
refinement, as well as prospective validation by other investigators.  This study 
suggests that a clinically meaningful population of difficult-to-sedate children 
requiring mechanical ventilation for a critical illness exists.  Documentation of this 
phenotype promotes the development of evidence to support best practices in 
the care of these children. 
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Chapter 1 
                                            Introduction 
The Problem 
Each year more than 115,000 critically-ill children receive sedation to help them 
tolerate intubation and mechanical ventilation.1 A significant number of these children do 
not respond as expected to appropriately dosed sedation and remain agitated for some 
period of time, leading to iatrogenic injury and increased stress.2-5 Over the course of the 
critical care admission, children who remain under-sedated despite optimal therapy are 
considered by the clinical team to be difficult-to-sedate, but little is known about this 
group of children to allow prospective identification.  By the time the child is identified as 
difficult-to-sedate, excessive and potentially avoidable burden has been placed on the 
child and family; resource requirements to ensure the child’s safety have increased; and 
injury may have occurred. 
Prospective identification of these children has been hampered by a variety of 
factors.  Intensive care sedation is a complex phenomenon, impacted by multiple 
variables.  Easily implemented, valid and reliable instruments that describe sedation 
levels in children have only become available and widely used in the last decade.  The 
age range of the patients cared for in the pediatric intensive care unit (PICU) is wide and 
encompasses enormous physiological and psychosocial differences.  Although well 
studied in adults, there are limited data on the metabolism and elimination of drugs 
commonly used for sedation in children.6,7 Organ maturation and critical illness also 
affect the rate at which sedation medications are metabolized and eliminated from the 
body. The influence of psychosocial development in response to sedation has not been 
thoroughly described.  There may be a genetic basis8 for the difficult-to-sedate child.  
Finally, the unit-specific context in which the sedation is provided is important.  Each 
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PICU’s environment influences how and when sedation is delivered, the specific agents 
used to provide sedation, as well as the definition of appropriate or optimal levels of 
sedation.  Each of these factors combine to make studying the phenomenon of sedation 
in critically ill children challenging. 
Defining sedation-related clinical phenotypes in critically ill children would 
facilitate better clinical management of these patients while avoiding harm. Specifically, 
accurate prediction of an individual child’s response to sedation would allow the 
selection of individualized therapy and contribute to improved clinical outcomes. 
Jameson and Longo,9 in their discussion of precision medicine, acknowledge the 
contribution of phenotype: “treatments targeted to the needs of individual patients on the 
basis of genetic, biomarker, phenotypic or psychosocial characteristics that distinguish a 
given patient from other patients with similar clinical presentations”. High doses of 
sedatives, and the simultaneous use of multiple agents, as typically occurs in the difficult 
to sedate child, generally results in significant side effects.  Identifying and providing 
targeted sedation strategies most effective for the difficult-to- sedate child will avoid 
these side effects. 
To date, the difficult-to-sedate child clinical phenotype has not been described. In 
other populations, advanced statistical methods have been used to analyze large 
datasets and identify different phenotypes within a specific disease process.  Howrylak 
and colleagues10 provide one example. They examined clinical data from 1041 children 
with asthma using cluster analysis to identify differences between clusters in terms of 
pulmonary function and response to inhaled anti-inflammatory medication. Five patient 
clusters were identified based on differences in three features. They identified that 
membership in a specific cluster predicted the child’s long-term asthma control and that 
two clusters which had the highest exacerbation rates responded differently to inhaled 
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corticosteroids. The authors concluded that phenotypic clustering effectively identified 
consistent and clinically relevant patient subgroups, with implications for targeted 
therapies.   
Using latent class modeling, Calfee et al11 analyzed data for 1022 subjects 
enrolled in two randomized controlled trials investigating acute respiratory distress 
syndrome.   They identified two phenotypes within the population which had differing 
clinical and biological characteristics, differing responses to treatment, and differing 
outcomes.  Members of phenotype 2 had severe shock, metabolic acidosis, high 
vasopressor use and higher levels of inflammatory biomarkers. They also had worse 
outcomes. 
 In the case of intubated and sedated children, the difficult-to-sedate child clinical 
phenotype might include a combination of demographic, physiological and 
developmental factors.12-14 Concept analysis is an ideal methodology to identify 
candidate variables key to describing the clinical phenotype. The purpose of identifying a 
concept (what something is or how it works) is to develop a mechanism to describe and 
illuminate a phenomenon of interest.  Walker and Avant15 have developed and refined a 
process through several iterations which provides a systematic and thoughtful 
mechanism to achieve that goal.  An important aspect of their method is that after a 
concept is identified, it must be clarified to clearly differentiate it from other concepts. 
This is done through careful examination of the structure and function of the concept.  
This requires examination of a concept’s basic, essential elements in order to develop a 
clear, precise operational definition of the concept of interest.   
This dissertation seeks to provide a comprehensive description of a clinical 
phenotype of critically ill children who demonstrate an under-sedation response, 
specifically, the difficult-to-sedate child clinical phenotype.   
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The specific aims for this dissertation are as follows: 
1) To explore key variables thought to be associated with the difficult-to-sedate 
child, propose a conceptual model linking those variables in critically ill 
pediatric patients, and develop an operational definition of the difficult-to-
sedate child.  (Method: Concept analysis that includes a systematic review of 
the literature) 
2) To assess both face and content validity of the candidate variables identified 
through the systematic review and incorporated in a preliminary model. 
(Method: Survey of the Pediatric Acute Lung Injury and Sepsis Investigators 
(PALISI Network and the Society of Critical Care Medicine (SCCM) Pediatric 
Sedation Study Group) 
3) To build and test a statistical model describing the difficult-to-sedate child 
clinical phenotype. (Method: Statistical modeling of an existing clinical dataset 
of 2449 critically ill children)  
Hypothesis: The difficult-to-sedate clinical phenotype can be described in 
 critically ill children.   
Approach  
The overall strategy for this dissertation will be: 1) to complete a concept analysis 
using the methodology described by Walker and Avant15 that includes a systematic 
review of the pertinent literature resulting in a clear operational definition and framework 
of the difficult-to-sedate child clinical phenotype.  The definition proposed in the current 
chapter will be modified based on the findings from the concept analysis. The 
operational definition and framework ultimately will be used to construct a statistical 
model which describes the key factors impacting the level of sedation achieved in 
critically ill children; 2) to establish face and content validity of the candidate variables 
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identified and explore additional unpublished variables to be incorporated in the model 
through a survey of expert pediatric critical care clinicians; and 3) to build and test the 
final model constructed using an existing clinical dataset of 2449 critically ill children.  
The methodology, and analyses to be used to accomplish the specific aims of this 
project are described below. 
Three benchmarks for success have been identified as necessary to achieve the 
aims of this dissertation.  The first is completion of the systematic literature review, which 
will direct the initial model design.  The second benchmark will be achievement of a 
survey return rate of at least 50%, with attainment of an acceptable content validity index 
for at least half of the variables contained in the initial model and refinement of the initial 
model.  The final benchmark will be the statistical model describing the difficult-to-sedate 
clinical phenotype. 
Background  
Pediatric intensive care units (PICU) were developed to provide care to critically 
ill infants and children in a developmentally appropriate setting with a care team skilled 
in working with these patients.  One of the most common therapies provided in the PICU 
is invasive mechanical ventilation.16-21 It is difficult for children to understand and 
cooperate with this therapy, so they receive sedation to ensure safety, decrease fear 
and anxiety and promote comfort.22-27 Doses for sedation agents have generally been 
extrapolated from adult doses and sedation practices vary greatly between PICUs.22,26-30 
A small number of studies have identified developmental differences in both the 
pharmacokinetics and pharmacodynamics of drugs in children.6,30-37 
When children are sedated, effectiveness of sedation is generally assessed to 
ensure the target sedation level is achieved.  Use of objective monitors of sedation level, 
such as the Bispectral index (BIS) monitor have not correlated well with clinical 
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assessment of sedation level in critically ill children, so observational sedation 
assessment tools are generally used.38-41 Reliable and valid pediatric specific sedation 
assessment tools have been developed in the last ten years. Prior to their availability 
modified adult sedation assessment tools were used in most studies of critically ill 
children receiving sedation.42-47 When sedation targets are not achieved, children are at 
risk for adverse events such as unplanned extubation.4,48 Children who will be difficult-to-
sedate cannot be prospectively identified based on current knowledge.  One mechanism 
which shows promise is clinical phenotype identification.  Clinical phenotypes group 
patients by presentation and response to therapy, and facilitate the delivery of 
individualized and effective therapy. In contrast, biological phenotypes consider specific, 
measurable biological abnormalities and may be determined by a single specific 
abnormality, such as rate of drug metabolism.  Currently, there is no way to 
prospectively identify either the clinical or biological phenotype of the difficult-to-sedate 
child. Clinical phenotype identification is highly aligned with the National priority of 
Precision Medicine.   
PICUs across the US are a very heterogeneous group.  They vary dramatically 
on factors such as number of beds, availability of specialty services, ability to provide 
highly technical services such as renal replacement therapy or extracorporeal 
membrane oxygenation, and the educational preparation of nursing staff.  However, one 
element universal to all PICUs is that all provide mechanical ventilation to patients on a 
daily basis. Each year thousands of children are admitted to PICUs in the United States 
due to a critical illness or injury which requires endotracheal intubation to facilitate 
mechanical ventilation.17-20  At least 30% of children admitted to PICUs receive 
mechanical ventilation.1,17,18 The majority of these children receive sedation therapy to 
keep them safe, prevent patient-ventilator dyssynchrony and minimize the negative 
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effects of painful procedures and the often unpredictable and frightening 
environment.22,23,25-27 Appropriate levels of sedation change over the course of the child’s 
illness and are impacted by both anticipated and unanticipated events for the patient, 
such as transport off of the unit for tests and procedures.  
Sedation Agents  
Several surveys provide a description of the evolution of sedation practices in the 
PICU over time.23,24,26,27,29,49  In 1989 Marx and colleagues24 surveyed the directors of 
Pediatric Critical Care training programs in the United States and Canada to identify the 
sedative agents used and methods of delivery.  In total, 35 surveys representing a 75% 
response rate, were received.  At that point in time, opioids, benzodiazepines and chloral 
hydrate were identified as the most frequently used agents, and typically opioids and 
benzodiazepines were used in combination.  The most frequent mode of administration 
was intermittent dosing on an as needed basis.  Other adjunctive medications such as 
ketamine and barbiturates (e.g. thiopental, pentobarbital) were used less frequently, and 
generally for sedation related to procedures.  Few units identified a written protocol for 
sedation (5.9%). The primary goals of sedation use were to increase comfort and 
prevent unplanned extubation. Interestingly, respondents reported the “biggest problem” 
with sedation to be inadequate efficacy.24 
 In 1997 Rhoney et al26 surveyed all pediatric attending physician members of the 
Society of Critical Care Medicine on their use of sedative and neuromuscular blocking 
agents.  The response rate was 51%, 145 pediatric critical care units were represented, 
and the findings were similar to those of Marx and colleagues. Opioids and 
benzodiazepines were the drugs most often used for sedation, given as continuous 
infusion or intermittent bolus dose.  Drugs indicated as being “routinely” used for 
sedation, in order of frequency, included fentanyl, midazolam, morphine and lorazepam. 
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Adjunctive medications such as ketamine, chloral hydrate and propofol were 
“occasionally” used.  The indications cited most often for use of sedation were 
management of anxiety and fear, amnesia, and facilitating mechanical ventilation.  A 
sedation protocol was used in 13% of units.  A sedation scale was used to monitor the 
level of sedation in 36% of units, almost equally divided between the COMFORT scale42 
and a scale developed by the respondent’s institution. 
In 2003 Twite et al27 surveyed Fellowship directors at 59 pediatric critical care 
training programs in the United States.  The return rate was 60%; 35 surveys were 
received.  Agents used for sedation were similar, but the ranking of those most 
frequently used sedatives had changed.  Midazolam, rather than morphine was the most 
frequently used agent, with lorazepam second in frequency of use, and morphine third.  
These medications were most frequently delivered as continuous infusions, with both a 
sedative and analgesic being administered simultaneously.  Chloral hydrate use had 
decreased from 68% of respondents reporting “frequent” use to 37% of respondents.  
Propofol and dexmedetomidine became available in the interval between the two 
surveys, and propofol in particular was used regularly.  “Frequent” propofol use was 
reported by 29% of respondents, while only 3% of respondents reported frequent use of 
dexmedetomidine.  Of note, 49% of units reported regular use of patient controlled 
analgesia.  Use of adjunctive medications continued, most commonly to manage 
medication withdrawal symptoms.  The number of units with a written sedation protocol 
increased from 5.9% to 66%.  Overall satisfaction with the ability to provide optimal 
sedation increased compared to the previous survey, with respondents indicating that 
children were mainly “occasionally” difficult-to-sedate. 
 Kudchadkar23 and colleagues surveyed an international sample of PICU 
intensivists, fellows, nurse practitioners and nurses.  The majority of the respondents 
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(70%) were from North American and were pediatric intensivists (also 70%).  Data were 
collected from July 2012 through January 2013.  The authors separate out data for North 
American respondents (n= 225) and those data are reported here, as there was 
variability between North American sites and all other countries in primary agent used, 
sleep promotion techniques, frequency of delirium assessment, and the study population 
used in this dissertation is drawn from the United States.  Availability of a sedation 
protocol was identified in this survey as 20% of PICUs, although this survey defined a 
sedation protocol as including a treatment algorithm, which is a more specific criterion 
than the two previous surveys.  Fentanyl and midazolam were the two most frequently 
used agents, at 76% and 82% respectively, and were generally used in tandem.  
Continuous infusion as the method of delivery was by far the most frequent choice, at 
80%.  Scheduled intermittent dosing was used by 10% of units.  The regular use of 
dexmedetomidine increased to 10%.  This survey also reported on which team member 
managed the sedation protocol, and 58% of units reported using a nurse-managed 
protocol.  A frequently identified frustration was inconsistency between team members in 
sedation goals.  Although the method of distribution and roles of individuals completing 
the survey varied significantly from the previously reported surveys, comparison of 
sedation practices over time shows an increased use of synthetic opioids (i.e., fentanyl), 
increased use of midazolam, and continuous infusion as the strongly preferred mode of 
sedation medication delivery. 
 Review of the literature over this period demonstrates the continued use of 
adjunctive agents and the search for newer agents less likely to result in tolerance and 
iatrogenic withdrawal syndrome.  Dexmedetomidine50-57, propofol58-61, and clonidine62 
have been the subject of a few clinical trials.  Whalen57 reported that dexmedetomidine 
was most frequently used when the desired sedation target was not able to be met using 
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opioids and benzodiazepines.  Ketamine, clonidine and pentobarbital are also frequently 
added as additional sedatives when opioids and benzodiazepines have been escalated 
to high doses due to tolerance or when sedation targets have not been achieved.  Other 
drugs which continue to be used as adjunctive sedation agents are diphenhydramine, 
lorazepam and chloral hydrate. 
 A major concern with the use of propofol in critically ill children is the significant 
incidence of propofol infusion syndrome, which manifests as bradycardia, renal failure 
and severe lactic acidosis. It is thought to be related to long-term use of the drug.   
Propofol infusion syndrome has resulted in several pediatric deaths.63 As a result, the 
FDA required a Black Box warning, it’s highest level of warning which indicates a serious 
or life-threatening risk, for propofol related to pediatric use.  The propofol package insert 
indicates “Propofol injectable emulsion is not indicated for use in Pediatric ICU sedation 
since the safety of this regimen has not been established. (See PRECAUTIONS - 
Pediatric Use.)”64 However both propofol and dexmedetomidine are often used as a 
bridge to extubation.  For example, these drugs, which have a short half-life, are started 
as a continuous infusion in the hours prior to a planned extubation, allowing longer 
acting sedation agents to be weaned in preparation for extubation while maintaining an 
acceptable level of sedation.61,65,66 This strategy is often used with children who do not 
tolerate being awake and mechanically ventilated.  The duration of infusion in this 
situation is recommended to be 12 hours or less.  Table 1 describes medications 
commonly used for sedation in the PICU 
Developmental Issues and Child Characteristics Related to Sedation 
 There have been a limited number of studies done to establish the 
pharmacokinetic and pharmacodynamics properties of most of the agents used to 
provide sedation to critically ill pediatric patients. Up to 80% of the drugs prescribed to 
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hospitalized infants and children are prescribed “off label,” meaning there is a lack of 
evidence to support their safety and efficacy in pediatric patients.7,28,29 When identifying 
appropriate dosing of sedation agents, pediatric prescribers generally extrapolate a dose 
from the recommended adult dose.  This practice assumes that the relationship between 
drug dose and drug concentration (i.e., pharmacokinetics [PK]) and drug dose and drug 
effect (i.e., pharmacodynamics [PD]) is the same in infants, children and adults.28,67  
 The PK and PD studies that have been carried out in both healthy and critically ill 
pediatric patients generally show that there is a difference in drug clearance, elimination, 
and response between neonates, infants, children and adolescents.6,30,31-37,68 However 
the number of subjects enrolled in these pediatric studies is generally very small, limiting 
the generalizability of findings.57,67-69 For example, four studies of midazolam PK and PD 
in critically ill infants and children reported in the period between 2002 and 2008 
included a total of 15 pediatric subjects.33,34,68,70 Factors related to changes in growth and 
maturation of organs and physiologic systems such as protein expression and protein 
function drive these differences.6,28,30 
 Maturation may increase or decrease drug receptor affinity for a particular drug 
and may alter signal transduction.6,71  Changes in body composition, such as the 
decrease in total body water or increase in adipose stores that occur as a child grows, 
affect drug distribution and availability.30,71  For example, neonates and young infants 
have lower adipose stores than older infants and children, and the adipose tissue of 
neonates has a higher ratio of water to lipid.6 As a result, neonates and young infants 
have a decreased volume of distribution of lipophilic drugs such as midazolam or 
fentanyl.  Thus, they will have a higher peak drug concentration than older children in 
response to the same dose.67 Maturation of drug metabolizing enzyme pathways and 
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increasing renal function with greater age also account for variability in the PK or PD of 
specific drugs.6,30,67,71 
 Midazolam clearance is decreased in infants.  The clearance rate increases with 
age, and a clearance rate similar to adults is seen at around 5 years of age.67  deGast 
Bakker33 and colleagues identified that one to four year olds required higher midazolam 
doses per kilogram of body weight than other age groups.  Morphine clearance in infants 
is approximately 80% of that seen in adults.  As a result, an increase in dose per 
kilogram from 5 mcg/kg at birth to 18 mcg/kg at 1 year is required to achieve steady 
state serum levels.31 Fentanyl also has a higher clearance rate in infants and children.72 
Pentobarbital PD and PK are affected by both age and weight36 and pentobarbital half-
life is significantly longer in neonates and infants.72 Critical illness compounds these 
developmentally driven effects. For example, Ince68 and colleagues found decreased 
midazolam clearance in critically ill children compared with pediatric oncology patients 
receiving procedural sedation and healthy infants receiving postoperative sedation. 
In addition, sedative use in infants and young children has been associated with 
long-term cognitive dysfunction. Few well-designed studies that can link specific 
sedation agents to cognitive outcomes have been completed to date, and results of 
some studies have been contradictory. 73-78   Studies of anesthetic agents are currently 
underway, as are studies examining cognitive outcomes in children who received 
sedation during a PICU admission.  This will be an important area of investigation to 
follow as findings will impact sedation practices in the future. 
Little research has been done in the area of psychosocial development and its 
relationship to sedation outcomes.  A child’s ability to manage negative stress and the 
coping strategies employed change as the child develops, and is linked to the child’s 
ability to comprehend the current situation.79 Innate child characteristics may also impact 
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response to sedation.  A single study linking child temperament to sedation outcome in 
the setting of procedural sedation demonstrated that inflexible temperament was a 
predictor of sedation failure.80 Although not commonly assessed, obtaining information 
on temperament or coping behaviors from parents of critically ill children could be an 
interesting area of investigation, and add to the characterization of the difficult-to-sedate 
child. 
Sedation Assessment Tools 
Several pediatric sedation scoring tools have been developed, and are used in 
PICUs across the US and internationally. Commonly used tools include the State 
Behavioral Scale (SBS),43 COMFORT Scale,42 COMFORT-B scale,44 Motor Activity 
Assessment Scale,81 and the Pediatric Sedation-Agitation Scale.45 The previously 
referenced sedation practices surveys demonstrated the development and increased 
use of validated pediatric sedation assessment tools over time.23,24,26,27 The 1989 survey 
by Marx et al24 did not reference an assessment tool at all.  Clinical impression of the 
physician and nurse were the most frequent mechanism of assessment, with 
assessment of vital signs and response to procedures also considered.  In the 2003 
survey, Twite27 et al included both analgesia and sedation scoring tools.  Both adult and 
pediatric tools were being utilized. The pediatric specific COMFORT score was the most 
commonly used tool (49%), followed by the adult Motor Activity Assessment Scale 
(11%).  The 2013 survey23 is reflective of current practice.  Pediatric specific sedation 
scoring tools are most commonly used, with 22% of PICUs reporting use of the State 
Behavioral Scale and 21% reporting use of the COMFORT scale, although 21% of 
PICUs continue to use the Richmond Agitation-Sedation Scale, a tool validated only in 
adult patients (e.g, RASS).82 Table 2 provides a description of sedation tools commonly 
used in the PICU. 
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Adequate and inadequate sedation exist along a continuum, and despite the 
development of valid and reliable instruments to assess sedation, assessment of 
adequacy of sedation is subjective.  Although work is ongoing to develop an objective 
measure of level of sedation, such as the BIS monitor, SNAP II (Stryker, Kalamazoo, MI) 
or auditory-evoked potentials no objective measures have proved reliable and consistent 
in the PICU population.38-41 There is strong evidence that sedation practices are 
influenced by personal, social, and professional factors.83-86 Variability in assessment of 
level of sedation is frequently seen in children who are moderately to deeply sedated, 
and this is seen when raters are of the same or different provider categories.40  
At the other end of the spectrum, assessment of children who are not well 
sedated and are in fact agitated generally shows more consistency.  This is can be 
related to the use of sedation as a means to protect children who are unable to tolerate 
the intensive care environment and are perceived to be in an unsafe state.  Terms such 
as refractory agitation, sub-optimal sedation, inadequate sedation and under-sedation 
are used to describe children at this end of the sedation spectrum.87-89 The scales used 
to describe level of sedation use terms such as “intermittently unsafe” or “unsafe (biting 
endotracheal tube, pulling at catheters, cannot be left alone”,43 “panicky”,42 “pulls on or 
removes tube(s) or catheter(s) or has aggressive behaviors toward staff” or “cannot be 
left alone”,82 “dangerously agitated, uncooperative- patient is pulling at tubes or 
catheters OR thrashing side to side OR striking at staff OR trying to climb out of bed”,81 
and “dangerous agitation- pulling at endotracheal tube, thrashing side to side, climbing 
over bedrails, hitting or kicking at staff, yelling or screaming at staff”.45 Children who are 
at this end of the sedation spectrum raise significant levels of concern for parents, who 
worry that children will injure themselves and who also perceive their child as suffering.  
Agitated children increase the level of concern for care providers as well, who are 
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concerned that the child will suffer physical harm, physiologically decompensate, remove 
invasive tubes or catheters that will be difficult to replace, or possibly suffer long-term 
psychological consequences of their agitated state.  Children who are inadequately 
sedated may remain in this state for significant amounts of time, despite regular 
adjustment and addition of medications, requiring increased staff resources to ensure all 
patients receive the needed attention. 
Clinical states associated with ongoing agitation, such as hypoxia, pain, delirium 
and children near the end of life,88-91 have been identified but there are very little data on 
factors which predict children who will become and remain agitated, despite aggressive 
treatment.  
Adverse Events Related to Under-sedation 
Despite the best efforts of the care team, up to 24% of children fail to respond to 
usual sedation therapy and will require higher dosages and sedative drugs from three or 
more drug classes in order to achieve the desired level of sedation.89,92 High dosages 
and the use of multiple sedative agents (i.e., polypharmacy) place these children at 
significant risk for sedation-related adverse events such as iatrogenic withdrawal 
syndrome, infection and pressure ulcers.   
During the startup phase of the RESTORE study, Grant,4 et al completed a 
systematic review in order to define and provide estimates of PICU specific sedation-
related adverse events (AE).  Of the eleven AE identified, five were directly related to 
agitation. Inadequate sedation management was defined as “Agitation defined by an 
SBS > 0 (or “assumed agitation present” in patients receiving neuromuscular blockade) 
for 2 consecutive hours not related to a planned extubation attempt” (p. 1318).  Based 
on their systematic review the event rate for this AE was estimated as expected in less 
than 10% of patients.  Clinically significant iatrogenic withdrawal was expected to occur 
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in less than 75% of patients. Unplanned endotracheal tube removal had an expected 
event rate of less than 3.0 per 100 ventilator days. Unplanned removal of any invasive 
tube could not be estimated but was tracked as an anticipated AE. Ventilator-associated 
pneumonia was identified as a sedation related AE with an expected event rate of less 
than 3.2 infections per 1000 ventilator days. New tracheostomies were tracked as a 
marker for extreme airway trauma secondary to agitation. 
These sedation-related AEs are also supported by more recent work.  Payen5 et 
al identified the use of continuous intravenous sedation as a risk factor associated with 
prolonged invasive mechanical ventilation in critically ill children, which in turn is 
associated with increased morbidity and mortality.  Gautam3 and colleagues identified a 
relationship between ventilator-associated pneumonia and prolonged invasive 
mechanical ventilation in pediatric patients. Best2 et al. identified duration and cumulative 
dose of opioid and benzodiazepine therapy as risk factors for iatrogenic withdrawal 
syndrome in critically ill pediatric patients. 
After initiation of the RESTORE study, Grant48 et al. completed a prospective 
observational study of 308 subjects from 22 PICUs who were enrolled in the baseline 
phase of the study, in order to test the previously developed operational definitions and 
estimate rates of occurrence of these sedation-related AEs.  The most frequently 
occurring AE was inadequate sedation management.  Agitation, identified as noted 
above, was documented in 30% of subjects and represented 41% of all AE.  Clinically 
significant iatrogenic withdrawal was documented in 8% of subjects and represented 
29% of all AE. The unplanned endotracheal tube extubation rate was 0.82 per 100 
ventilator days.48  These results clearly show that critically ill children who require 
intubation and mechanical ventilation experience a significant number of adverse events 
related to agitation, a key behavior observed in children labeled as difficult-to-sedate. 
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Clinical Phenotypes 
Clinical phenotypes have been developed as a way to describe patterns of 
presentation and response to therapy in an effort to provide the most appropriate and 
effective care in a timely way. Defining sedation-related clinical phenotypes in critically ill 
children would facilitate sorting these patients into subgroups, allowing specific therapies 
to be targeted to particular subgroups based on that subgroup’s unique clinical and 
physiological characteristics.  
In the last 10 years there has been a growing use of clinical phenotyping, 
sparked by completion of the Human Genome Project in 2004.  Once the entire Human 
Genome had been sequenced, researchers began to investigate whether linking clinical 
phenotypes to variation in specific genes would facilitate identification of subgroups of 
patients with a particular disease process who would benefit most from tailored therapies 
or “precision medicine”.   
Precision medicine has become a priority for the nation. In his 2015 State of the 
Union address President Obama announced a $215 million dollar line item for the 
Precision Medicine Initiative.93 As defined by the Precision Medicine Working Group94 
“Precision medicine is an approach to disease treatment and prevention that seeks to 
maximize effectiveness by taking into account individual variability in genes, 
environment, and lifestyle.” The goal of this initiative is to “pioneer a new model of 
patient-powered research that promises to accelerate biomedical discoveries and 
provide clinicians with new tools, knowledge, and therapies to select which treatments 
will work best for which patients.” Stated simply, the goal of precision medicine is to 
“deliver the right treatment to the right patient at the right time.”93  
Having phenotype information would facilitate more effective ways to treat 
disease.95  A defined clinical phenotype facilitates the classification of a patient into a 
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clearly identified sub-group of a specific clinical state that responds to specific therapies 
in a typical fashion for the sub-group.  The utility of clinical phenotypes is that 
identification of these homogeneous subgroups of patients facilitates research specific to 
the phenotypic group to determine risk factors or unique response to particular therapies 
within the group.96 This knowledge then guides targeted therapy, with the goal that 
members of the clinical phenotype receive the most appropriate and effective care in a 
timely way.   
Descriptions of clinical phenotypes can be found in the biomedical literature 
beginning in the 1960s. Usually associated with specific disease entities, and therefore 
described in a clinical setting, clinical phenotypes describe patterns identified in a 
patient’s presentation and response to therapies.  The clinically observable 
characteristics used to identify these patterns may be morphological, physiological, or 
biochemical.  Clinical phenotypes tend to be subsets of an overarching diagnosis: 
chronic obstructive pulmonary disease97 and hypertension98 are examples of diseases 
where specific clinical phenotypes have been well described. 
The clinical dimensions of clinical phenotypes are most often described in terms 
of physical assessment findings.  For example, type of wheezing is a key assessment 
finding in children with asthma.  Depner,99 et al. used wheezing types such as 
multitrigger wheeze, unremitting wheeze, recurrent unremitting wheeze, or episodic 
wheeze as an important way to characterize pediatric asthma clinical phenotypes.  In 
sickle cell disease, benign or severely affected clinical phenotype assignment is based 
on clinical dimensions that include severity of pain crisis, frequency of hospital 
admissions, and complications.100 Knowledge of these assessment findings and the 
resulting patterns suggested prompts the care provider to place the patient in a specific 
sub-group or category; that is, to assign a clinical phenotype. The usefulness of 
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identifying a clinical phenotype is that this categorization results in a meaningful benefit 
to the patient.  Identifying the clinical phenotypes within a disease identifies groups of 
patients who may have an increased need for or respond differently to the typical 
therapies used to manage the disease.  This guides the clinician in selecting the most 
appropriate therapies for that patient. 
In order for clinical phenotypes to be useful in clinical practice, three elements 
must be present:  a clinical condition or disease process, other patients who also have 
the clinical phenotype, and clinicians who can recognize the patterns of and identify the 
clinical phenotype.101 Having knowledge of the clinical phenotype and the typical 
response to therapy can result in earlier treatment, more appropriate drug selection, and 
anticipation and avoidance of adverse outcomes.  An important aspect of clinical 
phenotype is that it must be clearly articulated, so that it is readily applied by the 
clinician.  If not, a patient could be misclassified, resulting in inappropriate treatment, or 
not receiving needed treatment. 
Clinical phenotypes are clinical entities, and although the majority of the literature 
discusses specific disease processes, clinical phenotypes can also be identified as 
subgroups of patients that respond to specific therapies in a typical and consistent 
fashion for the subgroup. Knowledge of the sub-group’s response allows the clinician to 
predict the trajectory of the clinical course and select appropriate therapies for the 
patient that result in beneficial outcomes. 
It is known that patients have variable responses to sedation.  Clinical 
phenotypes can be identified and used to categorize patients who require more or 
different sedation to promote best outcomes.  Although there is thought to be a genetic 
underpinning to sedation response,8 it is the clinical manifestations of the sedation 
clinical phenotypes that have immediate impact on the patient, family and clinician.   
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To date, data to allow prospective identification of the difficult-to-sedate child 
clinical phenotype do not exist.  Identifying this phenotype may allow early identification 
of these patients and facilitate development of preventive strategies such as 
environmental manipulation and individualized sedation plans which could avoid adverse 
effects resulting from inadequate sedation.  Latent class analysis, cluster analysis and 
classification and regression tree analysis are some of the advanced statistical methods 
that have been used to analyze large datasets and identify differentiating factors which 
describe different phenotypes within a specific disease process, such as asthma,99,102-104 
sepsis105 or chronic obstructive pulmonary disease.101  In the case of intubated and 
sedated children these differentiating factors might include demographic, physiological, 
developmental, and clinical factors.12-14 
Significance 
A well articulated clinical phenotype for the difficult-to-sedate child would support 
further investigation related to sedation in critically ill pediatric patients by establishing a 
definition that could be used consistently by investigators.  It also might allow early 
identification of the child at risk for under-sedation, which would facilitate more 
appropriate, targeted management.  As a result the care team could ensure the child 
rapidly achieved the targeted sedation goal by selecting the most effective sedation 
agents at appropriate doses for that child, while minimizing the risk of adverse events. 
Identification of this clinical phenotype will assist in the development of personalized 
targeted therapy to minimize the negative effects of excessive sedation medications.  
Identification of this clinical phenotype will then inform future work on the identification of 
a genetic phenotype for this group of children. 
Innovation 
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Use of a clinical phenotype to describe response to sedation in a critically ill 
pediatric population is a novel way to approach the problem of under-sedation.  To date 
no research has utilized this approach. Identifying the demographic, physiologic, and 
developmental characteristics associated with differing responses to sedation will assist 
the care team to provide specific and individualized sedation strategies for critically ill 
children.  This goal is in keeping with current, innovative research in other areas, which 
seeks to identify targeted therapies.  Additionally, identifying a group of children who fall 
into this clinical phenotype could facilitate an investigation for specific genetic 
phenotypes that underlie the clinical phenotype.   
This study will take advantage of a unique data set from the Randomized 
Evaluation of Sedation Titration for Respiratory Failure (RESTORE) study16 
(ClinicalTrials.gov identifier NCT00814099.21), a previously developed data set 
containing highly detailed sedation-specific data in critically ill children to identify 
characteristics of this clinical phenotype. This approach is also innovative, and 
represents an effort to maximize the use of data and respect the contributions of over 
2400 children and their families.   
Introduction to the Dissertation Format  
The proposed dissertation consists of three papers, outlined in Table 3. The first 
paper will present the results of a concept analysis using the methodology described by 
Walker and Avant15 that includes a systematic review of the pertinent literature resulting 
in a clear operational definition and framework of the difficult-to-sedate child clinical 
phenotype.  The operational definition and framework will be used to construct a 
conceptual model, which describes the key variables impacting the degree of sedation 
achieved in critically ill children.  Paper 2 will describe the process used to establish face 
and content validity of the candidate variables identified and seek additional factors to be 
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tested through a survey of expert pediatric critical care clinicians.  Paper 3 will 
investigate a large cohort of children who received sedation while intubated for acute 
respiratory failure, building and testing the final model developed to identify subjects who 
are members of the difficult-to-sedate child clinical phenotype.    
Paper 1 
Title: Describing the Difficult-to-Sedate Child: A Concept Analysis 
Target Journal: Journal of Pediatric Nursing 
Background: 
Sedation is routinely used in pediatric patients requiring intubation to facilitate 
mechanical ventilation, decrease anxiety and stress, and minimize the likelihood of an 
adverse event.23,24,26,27 Sedation targets are identified and sedation scores are utilized to 
determine if the desired target has been achieved.23,89 Pediatric sedation scales have 
been developed and their psychometric properties have been carefully 
examined.(sedation scale references)  The particular agents or combinations of agents 
used to achieve sedation in the PICU setting have been studied in order to identify the 
most effective agents which also have a good safety profile.  The specific agents used 
have evolved over time as newer and safer agents have become available.23,24,26,27 
A finding from these areas of investigation is that not all patients in the PICU 
achieve optimal sedation.23,45,49,89 Some of the potential reasons for this fall within 
clinicians’ control, such as inappropriate dosing of sedation agents, lack of 
environmental controls, uncontrolled pain, or the limitation of parental involvement in the 
child’s care.  However a portion of this patient population does not achieved the desired 
sedation target despite increased doses and the addition of agents.  These patients 
have been identified as sedation failures or their level of sedation has been described as 
under-sedation.  Although it is well documented that this subpopulation is routinely seen 
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in the clinical setting, there is little known about the risk factors for under-sedation.  A 
clear mechanism does not exist for identifying which children will be difficult-to-sedate. 
Paper 1 describes a systematic literature review, which identifies variables 
associated with pediatric sedation in the critical care setting, specifically variables 
associated with the difficult-to-sedate child. This information was synthesized using the 
concept analysis methodology of Walker and Avant.15 The product of the concept 
analysis was a clear operational definition of the difficult-to-sedate child.  This 
operational definition was used to frame a conceptual model of key factors impacting the 
level of sedation achieved in critically ill pediatric patients cared for in the PICU. The 
model describes potential variables to test in the development of a clinical phenotype of 
the difficult-to-sedate child.  Table 4 lists other pertinent operational definitions.   
Research Question: What individual, process or system variables are identified in 
the literature as associated with the difficult-to-sedate child?  
Methods: A literature search of multiple databases, including PubMed, Medline, 
EMBASE, ISI Web of Science, Scopus, ProQuest Dissertations, CINAHL, and the 
Cochrane Database of Systematic Reviews and Central Register of Controlled Trials 
from January 1, 1985 through March 31, 2017 was completed in order to identify 
research articles specific to the topic of pediatric sedation in a critical care setting.   
Inclusion criteria:  The primary focus of the included studies was sedation for 
intubation or to facilitate mechanical ventilation in pediatric patients aged 2 weeks post 
conceptual age to 18 years cared for in a critical care setting.   
Exclusion criteria: Studies primarily focused on dental sedation, procedural 
sedation, perioperative sedation or sedation for comfort care were excluded. Studies that 
do not report a measure of sedation effectiveness will also be excluded. Abstracts of 
papers published in languages other than English were translated. 
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Study procedures: A literature search was conducted as described.  Additionally, 
reference lists of the articles retrieved were reviewed to identify additional studies for 
inclusion not identified in the initial search.  A flow diagram describing identification of 
the final group of studies included in the systematic review is provided in Chapter 2.   
Analysis Plan: A table of evidence was utilized to examine the studies reviewed.  
Data elements included in the table were: study population, setting, sample size, 
sedative agents used, sedation assessment mechanism and definition of under-sedation 
used in the study.  The Preferred Reporting Items for Systematic Reviews and Meta-
Analyses106 checklist was used to rate the quality of each included study. The table of 
evidence was used in the analysis of candidate factors for model construction, and a 
conceptual model was proposed and is described in Chapter 2. 
Paper 2 
Title: Appraisal of Face and Content Validity of Variables Associated With the Difficult-to-
Sedate Child in the Pediatric Intensive Care Unit: A Survey of Pediatric Critical Care 
Clinicians 
Target Journal: Australian Critical Care 
Background: 
Face and content validity are used to determine if items in a scale or survey are 
important and relevant to the topic, clear and understandable. This assessment seeks to 
determine if there are adequate and appropriate items to represent the phenomenon or 
construct of interest.107 Feedback from experts in the area under study is a method 
commonly used to assess face and content validity.  A high level of consensus among 
the group of experts supports face and content validity.   
Paper 2  describes the construction, deployment and results of a survey of 
pediatric critical care experts used to validate candidate model variables identified 
 25 
  
 
through the systematic review and concept analysis.  This group was asked to identify 
additional variables to consider for the model. 
Methods: To establish face and content validity for criteria to be used in a 
subsequent study identifying the difficult-to-sedate child clinical phenotype, expert 
Pediatric ICU clinicians who are members of a research consortium, the Pediatric Acute 
Lung Injury and Sepsis Investigators (PALISI) Network, and an expert study group, the 
Society of Critical Care Medicine (SCCM) Pediatric Sedation Study Group, were asked 
to complete a questionnaire using the Qualtrics (Provo, Utah) Survey platform. These 
groups were chosen because they include active, experienced critical care clinicians 
who provide pediatric sedation on a routine basis, and include a variety of providers 
including nurses, physicians, respiratory therapists and pharmacists.  The SCCM 
Pediatric Sedation Study Group is tasked with developing sedation-specific 
recommendations for the pediatric critically ill patient.  Recommendations on key 
elements to include when reporting surveys in publications generated by Duffett,108 et al 
were followed in the write up of this study.  
Inclusion criteria: All members of each group who are clinicians were included. 
Exclusion criteria: Individuals who completed the survey but are not clinicians, 
determined by response to a question asking the respondent to identify their role, were 
excluded. 
Procedures: The Institutional Review Board of the University of Pennsylvania 
determined that the study did not require informed consent from participants.  A 
questionnaire was developed containing questions used to assess face validity of 
variables included in the initial model. Two additional questions asked for the 
respondent's clinical role and organization. No other demographic information was 
collected.  
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In order to avoid coercion and maintain confidentiality, the survey was distributed 
by a member of each groups’ administrative staff to their email list. Investigators did not 
have access to the email list. Participation was voluntary. Submission of a survey was 
used as an assumption of consent. 
Respondents were asked to answer the questions in relation to a patient’s first 
four days of endotracheal intubation, with the assumption that the patient’s pain was 
adequately controlled and that sedation medication doses were appropriate. Survey 
participants were instructed to score each of the variable items as not (1), somewhat (2), 
quite (3), or highly (4) relevant in identifying the difficult-to-sedate clinical phenotype.  
Analysis: Descriptive statistics for the two demographic variables, including 
frequencies and percentages for nominal/binary variables were reported. All study data 
was examined carefully for invalid or outlying values, and distributional assumptions 
were assessed where appropriate. 
Primary analysis involved calculation of a content validity index,107 used to 
identify the factors which respondents felt best identified the difficult-to-sedate child. 
Items which scored a content validity index greater than or equal to 0.70 were retained in 
the model.  The final model created was tested as described in Paper 3. 
 The primary limitation of survey research is a poor return rate for surveys.109,110 In 
order to promote a high rate of return, survey responses were carefully tracked on a 
daily basis, and a reminder email was sent by the administrative staff one week after 
deployment of the original survey.   
The survey site captures all responses in a survey, even if the survey is not 
completed, so any data provided in all surveys initiated was captured.  However, the 
goal is to obtain complete surveys. The survey completion time was short, and the 
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survey site provided tools such as a completion bar and formatting for smartphones, 
which encouraged participants to complete the survey. 
Because the survey will be distributed via email, it is important that the survey 
program used be stable and accessible throughout the data collection period.  This 
survey site has been used extensively throughout the University of Pennsylvania, and 
has demonstrated good accessibility, stability and strong data protection and security. 
Paper 3 
Title: Characteristics of the difficult-to-sedate child phenotype 
Target Journal: Pediatric Critical Care Medicine 
Background: 
The aim of paper 3 is to characterize variability in sedation response within a 
cohort of 2,449 subjects enrolled in RESTORE and use data through the first three days 
after endotracheal intubation to operationalize and define the difficult-to-sedate child 
clinical phenotype. 
Typical, over- and under-responders to sedation were compared on 
demographic, physiological, developmental and clinical characteristics, as well as 
patterns of opioid, benzodiazepine, and other sedative medication administration with 
the goal of identifying the characteristics of the difficult-to-sedate child clinical 
phenotype.  
Methods:  A secondary analysis of the RESTORE data set was completed to test 
the hypothesis that a phenotype for the difficult-to-sedate child can be described. 
The RESTORE (Randomized Evaluation of Sedation Titration fOr Respiratory 
failure) study (U01 HL086622 and U01 HL086649) was a cluster randomized clinical trial 
designed to test an innovative approach to sedation management in pediatric patients 
supported on mechanical ventilation.16  The trial intervention consisted of daily 
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assessment of illness trajectory, establishment of an individualized sedation goal and 
implementation of a nurse-directed comfort algorithm that guided the sedation/analgesic 
management.  The sample consisted of 2449 critically ill infants and children supported 
on mechanical ventilation from 31 participating pediatric intensive care units (PICUs) 
between June 2009 and December 2013. The intervention tested in the trial sought to 
improve sedation management in pediatric critical care settings and to reduce the risk of 
sedation-associated complications such as failed extubation, iatrogenic withdrawal 
syndrome (IWS), and the development of ventilator associated pneumonia (VAP). 
Inclusion criteria: All RESTORE subjects who contributed at least two days of 
data. 
Exclusion criteria: None 
Procedures:  IRB approval for the parent study was obtained at all study sites.  
The parental permission document specifically allowed subsequent use of de-identified 
data.  Data points extracted from the RESTORE data set were identified based on the 
variables included in the final model. A cohort of difficult-to-sedate subjects within the 
RESTORE trial data set was generated and then compared to typical response 
RESTORE subjects.  This was done by developing a subset of patients who had both a 
sedation score indicating agitation and opioid and/or benzodiazepine doses above the 
standard dose range on the same day, during days 0 through 3, as this is likely the 
subset of patients that represent the difficult-to-sedate child clinical phenotype. Several 
iterations of models of the difficult-to-sedate child clinical phenotype were considered, as 
is standard for the type of analyses planned, in order to best define the phenotype. 
Analysis Plan: Using the RESTORE data set, pertinent clinical factors were 
identified. Latent Class Analysis111 was employed to characterize the difficult-to-sedate 
phenotype in children enrolled in the RESTORE trial. The analysis explored traits such 
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as number of inadequate sedation management events, number of sedative medication 
classes received, and standardized total daily sedation requirement to maintain target 
sedation goal. 
Latent Class Analysis (LCA), a hypothesis-free statistical technique, has been 
used extensively in clinical phenotype development studies to identify unobserved 
(latent) classes by building typologies or clusters based on observable variables within a 
data set.  We used LCA to analyze the RESTORE dataset, in order to characterize the 
difficult-to-sedate child clinical phenotype. LCA has been previously used to identify 
phenotypes in acute respiratory distress syndrome,11 pulmonary hypertension,112 
COPD,101 and wheezing phenotypes in young children.99,102,103  The model developed 
and refined in Papers 1 and 2 was tested in order to develop a final model which used 
an appropriate set of demographic and clinical factors as well as agitation-related and 
sedation-related characteristics to predict membership in the latent classes. This allowed 
characterization of the difficult-to-sedate child clinical phenotype.  
We also used Classification and Regression Tree (CART) analysis to identify risk 
factors for being difficult-to-sedate. CART methodology has been successfully used to 
identify risk in other populations, such as septic pediatric and adult patients,105 and is 
useful in uncovering complex interactions when many potential predictor variables and 
patterns of relationship exist.113 CART produces cut points and ordering of decision 
nodes that clearly discriminate between groups with high and low risk for the response 
variable.105,114 We used a randomly selected sample of subjects from the RESTORE 
database as the learning dataset, which was used to build the initial classification tree 
using RStudio (Foundation For Open Access Statistics, Boston, MA). Cross validation 
was used to identify the most accurate and predictive tree. We used the remaining  
subjects as the test dataset to validate the initially derived tree. These approaches allow 
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characterization of the difficult-to-sedate child who does not respond to standard therapy 
and requires a treatment approach that deviates from the norm, as well as associated 
risk factors based on demographic and clinical factors.   
Limitations, Assumptions, and Design Controls 
This study is a secondary analysis of an existing data set, which presents some 
potential limitations.91,115-120 A key issue is that the question of interest in the secondary 
analysis must fit the data available from the parent study. Operational definitions and the 
unit of analysis must be congruent.117 In this case a subset of the parent study data 
specifically matches information needed to answer the question of this study.  For 
example several data points related to sedation levels, as well as daily amounts of 
sedation medications and the number of different agents used for sedation was collected 
in the parent study.  The unit of analysis for this study will be the individual subject, 
which matches the parent study.   
A potential problem is the inability to identify the difficult-to-sedate child 
phenotype. This may occur because the data may be too noisy and a group of 
characteristics may not be able to be identified. If this is the case, an alternative strategy 
is to calculate a cumulative difficult-to-sedate score for each subject, based on the 
previously identified variables and use linear regression and structural equation 
modeling to identify which variables predict the difficult-to-sedate child phenotype. A 
second potential limitation is that methodological issues may exist related to the parent 
study.116-118 The parent study methodology was reviewed by Institutional Review Boards 
of the 31 sites which enrolled subjects, as well as the funding organization, the National 
Heart, Lung, and Blood Institute of the National Institutes of Health.  A related potential 
methodological issue is that the parent study was a cluster-randomized trial, with sites 
being randomized to the intervention or control arms.  The possibility exists that if there 
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were significant differences in sedation practices between the control sites, the data 
could be skewed.  Careful evaluation of data considering treatment arm assignment will 
allow identification of any impact of this aspect of the study design.  
When using a previously created data set, quality of the data is a potential 
limitation, specifically concerns that the data is outdated or inaccurate.116-120 The parent 
data set in this case has a high level of quality.  A key variable of interest in this study is 
sedation scores, obtained by direct assessment of subjects.  Multiple procedures were 
implemented at each site to ensure accuracy.  Medication data is another variable of 
interest, and this data was carefully reviewed by monitors over the course of the study to 
ensure data accuracy.  The parent data set was carefully cleaned to minimize missing 
data.  If questions arise about the data set, the study investigator will have ready access 
to the parent study principal investigators as well as the Data Coordination Center, which 
is where all data is held.  In terms of concerns that the data is outdated, the parent data 
was collected over a five year period, from 2008 to 2014.  Data analysis for the present 
study is anticipated to occur in 2016-2017.  This represents a minimal time lag and 
reduces the risk that the data will be outdated. 
If the parent data set is not representative of the population of interest, a concern 
arises that there will be limited generalizability.  Entry criteria for the parent study and 
missing data, which may decrease power, are both potential concerns.115-120 As noted, 
the parent data base was constructed to minimize missing data and was thoroughly 
cleaned.  The parent study included children intubated specifically for respiratory 
causes, which limits generalizability to the entire PICU population.  Although the most 
frequent diagnosis associated with intubation in the PICU is respiratory failure, children 
are also intubated for reasons such as control of intracranial hypertension, protection of 
a surgical incision, or manipulation of cardiopulmonary dynamics.  The exclusion of 
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children with “Do not resuscitate” status also limits the ability to generalize to a group 
known to present sedation challenges.91 The present study is exploratory and as a 
result, information gained in this study will provide direction for subsequent studies 
related to these populations. 
A final concern related to secondary analysis on an existing data set is that the 
parent study may not contain the variables needed to answer the questions posed in the 
secondary analysis.116,117 Because the variables of interest will be identified in papers 
one and two, this is a possibility, however, extensive data on variables likely to be of 
importance was collected in the parent study. 
Some assumptions have been made in designing the present study.  A key 
assumption is that when sedation levels were assessed, pain was controlled.  This 
assumption is based on the agreement of all participating sites to assess pain using the 
same tools and at the same intervals, with minimal assessment intervals of every four 
hours. There are several additional assumptions.  Factors known to be related to 
agitation have been appropriately managed; the environment is appropriate, ventilator 
settings are adequate; parent presence and participation in providing comfort to the child 
was facilitated; and initial starting doses of sedation medications were appropriate based 
on the child’s weight and clinical condition.  It is assumed that sedation assessments 
were accurate, the sedation level scoring tool was used correctly,122 and that 
medications were administered correctly and via an intact intravenous line or enterally, 
as appropriate.   
Summary 
 The three papers outlined in this discussion build progressively toward the goal 
of answering the primary question explored in this dissertation:  Can specific clinical 
phenotypes be identified for the critically ill child receiving sedation and mechanical 
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ventilation?  The systematic review of the literature and concept analysis in paper one 
resulted in construction of a model which proposes the key variables impacting the 
degree of sedation achieved in critically ill children.  Paper 2 describes establishment of 
face and content validity for the factors included in the initial model and seeks additional 
factors to be tested through a survey of expert pediatric critical care clinicians.  Paper 3 
describes testing of the refined model using the RESTORE dataset.   
The dissertation concludes by providing an in-depth discussion of the overall 
findings and significance of the completed work, the implications for research and 
practice stemming from the dissertation and how each of the three papers combine to 
contribute to the knowledge base of pediatric critical care. 
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APPENDIX 
 
Table 1:  
Medications Frequently Used for Sedation in the Pediatric Intensive Care Unit 
Drug Name Therapeutic Class Dose Range Notes 
Sedatives 
Midazolam Benzodiazepine hypnotic 
sedative 
0.06-1.2 mg/kg/hr Max 7 
mg/hr 
Lorazepam Benzodiazepine hypnotic 
sedative 
0.025 mg/kg/hr Max 2mg/hr 
Opioids 
Morphine Analgesic narcotic .01-.06 mg/kg/hr  
Fentanyl Analgesic narcotic 1-10 mcg/kg/hr  
Adjunctive Medications 
Chloral hydrate Hypnotic sedative 25-75 mg/kg/dose Max 2 
gm/dose 
Clonidine Sedative α2 agonist Oral: 3-6 
mcg/kg/day 
Transdermal: 0.05-
0.1 mg/d 
Oral daily 
dose is 
given every 
4-6 hours 
Dexmedetomidine Sedative α2 agonist 0.2-2.5 mcg/kg/hr  
Diphenhydramine Sedative 0.5 – 1 mg/kg  
Ketamine Dissociative general 
anesthetic 
Intermittent: 0.5 – 2 
mg/kg 
5-20 mcg/kg/min 
 
Methadone Narcotic analgesic 0.1 mg/kg/dose  
Pentobarbital Barbiturate, hypnotic 
sedative, general 
anesthetic 
1-2 mg/kg/dose  
Propofol General anesthetic 125-300 
mcg/kg/min 
< 24 hour 
limit on 
infusion 
Data compiled from references: 7, 22, 23, 25, 26, 52, 53, 55, 58, 61, 65, and 121 
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Table 2: Sedation Scoring Tools used in the Pediatric Intensive Care Unit  
Tool Author Target 
Population 
Descriptors Indicators Scale Reliability 
& Validity 
Testing 
Notes 
COMFORT42 Ambuel 
et al 
Pediatric ICU 
patients 
newborn to 
adolescent 
8 scale 
dimensions are 
each graded 1-5 
and summed to 
give a total score 
Alertness 
Calmness 
Respiratory 
activity 
MAP 
HR 
Muscle tone 
Facial 
expression 
 
8, unresponsive 
to  
40, Hyper-alert 
and active 
 
scores < 18 
may be used as 
an indicator of 
deep sedation 
Yes Global 
measure of 
comfort/dis
comfort, 
including 
pain; 
includes 
physiologic
al 
measures 
COMFORT-B44 Ista  
et al 
Mechanically 
ventilated 
pediatric ICU 
patients, 
newborn to 
adolescent 
6 of the 
COMFORT 
scale 
dimensions: HR 
and MAP 
removed 
Alertness 
Calmness 
Respiratory 
activity 
Muscle tone 
Facial 
expression 
6, unresponsive 
to  
30, Hyper-alert 
and active 
Yes Validity has 
also been 
evaluated 
in young 
children 
with Down 
syndrome47 
Pediatric 
Sedation 
Agitation 
Scale45 
Lyden  
et al 
Pediatric ICU 
patients 
newborn to 
adolescent 
Level of 
responsiveness 
Response to 
stimulus or 
movement 
1, unarousable 
to  
7, dangerous 
agitation 
Face and 
content 
validity 
only 
Adaptation 
of an adult 
scale 
Ramsay 
Sedation-
Agitation 
Scale81 
Sessler 
et al 
Adult ICU 
patients 
Level of 
responsiveness, 
behavior 
Response to 
stimulus or 
movement 
-5, 
unresponsive to 
+4, combative     
Adult 
populatio
n only 
One of the 
earliest 
sedation 
assessmen
t scales 
developed 
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State 
Behavioral 
Scale43 
Curley 
et al 
Mechanically 
ventilated 
pediatric ICU 
patients,         
6 weeks to 6 
years 
Level of 
responsiveness 
Level of 
alertness, 
respiratory 
activity, ability 
to calm 
-3 unresponsive 
to  
+2 agitated 
Yes  
University of 
Michigan 
Sedation 
Scale40 
Malviya 
et al 
 
Pediatric 
patients, 
newborn to 
18 year 
Level of 
responsiveness 
Level of 
alertness, 
response to 
stimulus 
0, awake to  
4, unarousable 
Validated 
for use 
with 
procedur
al 
sedation 
Top of 
score is 
awake and 
alert- no 
indicators 
for 
agitation 
 
MAP= mean arterial pressure HR= heart rate ICU= intensive care unit 
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Table 3: Manuscripts and Specific Aims 
Chapter  Specific Aim 
  
Chapter 2 
The Difficult-to-Sedate Child: A Concept Analysis 
 
To explore key variables thought to be associated with the 
difficult-to-sedate child, propose a conceptual model linking 
those variables in critically ill pediatric patients, and validate 
or refine the operational definition of the difficult-to-sedate 
child proposed in Chapter 1. 
  
Chapter 3 
Face and Content Validity of Variables Associated with the 
Difficult-to-Sedate Child  
in the Pediatric Intensive Care Unit: A Survey of Pediatric 
Critical Care Clinicians 
 
To assess both face and content validity of the candidate 
variables identified through the systematic review and 
incorporated in a preliminary model. 
  
Chapter 4 
 
 
To build and test a statistical model describing the difficult-
to-sedate child clinical phenotype. 
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Table 4: Operational Definitions 
Term Definition 
Sedation Level Child’s observable response to physical and 
environmental stimuli during the administration of 
medications intended to decrease the level of 
response, measured with a valid and reliable 
sedation scoring tool 
Sedation Goal Desired sedation scoring tool value to be achieved 
identified by the care team; based on the child’s 
illness trajectory and physiologic and psychosocial 
ability to tolerate activity, therapies, and 
environmental stimulation 
Appropriate Sedation Dose Dose of sedation medication which achieves the 
desired level of sedation, without causing 
physiologic instability 
Optimal Sedation Child consistently remains within the identified 
sedation goal range, without requiring frequent 
medication adjustments or additions 
Tolerance Decreasing clinical effect of a drug after prolonged 
exposure to it, requiring an increase in dose to 
achieve the same effect22 
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CHAPTER TWO 
The Difficult-to-Sedate Child: A Concept Analysis 
Target Journal: Journal of Pediatric Nursing 
Abstract 
Critically ill children requiring mechanical ventilation receive sedation to promote their 
comfort and ensure their safety.  Some children do not respond as expected to the usual 
sedative medications in typically adequate dosages and are considered “difficult-to-
sedate”.  A review of the literature indicated that the clinical characteristics of these 
difficult-to-sedate children have not been well described. The population of mechanically 
ventilated children examined was heterogeneous and included children from birth to 18 
years of age with a variety of medical and surgical diagnoses. The reported incidence of 
undersedation in this population varied widely by cohort studied.  Assessment 
instruments used to assess level of sedation also varied widely, with no agreement on 
the definition of undersedation. This paper provides a concept analysis of the 
phenomenon of the difficult-to-sedate child using the methodology of Walker and Avant. 
Analysis of the existing literature suggests the following operational definition: the 
difficult-to-sedate child is characterized as a mechanically ventilated critically ill child 
routinely requiring escalation of sedation doses beginning on day one of ICU care, as 
well as the routine administration of adjunctive medications, who reaches doses above 
the standard range within the first three days of intubation and remains above the target 
sedation goal. Given that these patients are seen in clinical practice, studies using valid 
and reliable measures are needed to test this definition in order to develop tailored 
treatment strategies. 
Keywords  
Child, pediatric intensive care, sedation, sedation assessment, concept analysis 
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Highlights  
• Children in pediatric ICUs receive sedation to ensure comfort and safety. 
• A subset of children do not respond to sedation as expected. 
• These children remain under-sedated despite receiving typically adequate 
sedative doses. 
• This group of “difficult-to-sedate” children have not been well characterized. 
• Effective characterization could lead to more appropriate targeted interventions. 
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The Difficult-to-Sedate Child: A Concept Analysis 
When a critically ill child remains agitated, despite providing adequate dosages of 
sedative agents, clinicians consider them “difficult-to-sedate”.  More than 115,000 
critically-ill children are admitted to pediatric intensive care units (PICUs) in the United 
States due to a critical illness or injury each year.(Agency for Healthcare Research and 
Quality, 2014) Sedation is routinely used in these patients to facilitate their comfort, to 
help them tolerate invasive therapies, to decrease their anxiety and stress, and to 
minimize the likelihood of an adverse event, including unplanned endotracheal 
extubation and removal of life-sustaining invasive catheters. 2-5    
Although sedation is a key element in pediatric critical care, not all patients in the 
PICU are able to be sedated and remain agitated despite receiving adequate dosages of 
sedative agents.2,6 Some of the potential reasons for this fall within clinicians’ control, 
such as not controlling pain, lack of day-night cycling, or the limitation of parental 
involvement in the child’s care.  However, a portion of these patients are not able to be 
sedated despite increased doses of multiple sedative agents.  Multiple terms have been 
used to describe these patients, for example, sedation failures or under-sedated 
patients.  This presents a problem because a clear operational definition of this 
phenomenon is necessary for systematic inquiry.  
This paper will identify the individual, process and system variables that help 
characterize the critically ill difficult-to-sedate child.  This information will be synthesized 
using the concept analysis methodology of Walker and Avant7 to produce an operational 
definition of the difficult-to-sedate child.  This definition will then be used to frame a 
conceptual model of key factors impacting the level of sedation achieved in critically ill 
pediatric patients cared for in the PICU, and ultimately to support further inquiry of the 
difficult-to-sedate child.  
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Methodology 
Walker and Avant’s7 concept analysis framework was developed to provide a 
methodical process for defining the core elements of a concept in order to develop an 
unambiguous operational definition which can then be tested. The purpose of identifying 
a concept (what something is or how it works) is to develop a mechanism to describe 
and illuminate a phenomenon of interest, in this case the difficult-to-sedate child.  An 
important aspect of their method is that after a concept is identified, it must be clarified to 
clearly differentiate it from other concepts. Careful examination of the structure and 
function of the concept through concept analysis results in concept clarification and 
differentiation.  This strategy requires examination of a concept’s basic, essential 
elements in order to develop a clear, precise operational definition of that concept.  The 
steps involved in concept analysis as described by Walker and Avant7 are very specific, 
and are detailed in Box 1.   
 The concept of the difficult-to-sedate child is highly pertinent to the clinical setting 
and to the clinical work of nurses caring for critically ill children with respiratory failure 
who require mechanical ventilation.  Benner, Kyriakidis, & Stannard8 describe how 
nurses learn to identify patterns of patient responses as they provide care to multiple 
patients over time and become skilled at using pattern recognition to respond to evolving 
clinical situations.  Nurses not only recognize and interpret these patient patterns but 
quantify the quality of the response for a particular group or sub-group of patients.  This 
concept, difficult-to-sedate, describes specific patterns that exist in the presentation and 
behavior of a subset of critically ill children while they are receiving nursing care.  
Analyzing and clarifying the concept of the difficult-to-sedate child will result in the 
development of an operational definition that will facilitate incorporating this variable into 
a conceptual model and allow testing of the variable.   
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Uses of the Concept and Defining Attributes 
Uses of the Concept 
 Patient sedation is pertinent to several disciplines, including nursing, medicine, 
pharmacy, and psychology.  In order to identify as many relevant studies as possible, 
multiple data bases were searched to identify original research whose focus was 
mechanically ventilated critically ill children 2 weeks to 17 years of age receiving 
sedation. Table 1 provides details of the databases searched, inclusion and exclusion 
criteria and the search terms used. A table of evidence (see Table 2) was constructed to 
synthesize study data.  Key areas of interest were sedation assessment method, 
definition of sedation categories used, incidence of undersedation, and any identified risk 
factors for undersedation.  The literature review was conducted and reported using the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines 
(PRISMA).9 Figure 1 provides the PRISMA diagram outlining the search results. The 
literature review findings emphasize the need for an analysis of the concept of interest. A 
clear operational definition of the difficult-to-sedate child was not identified. 
Sedation is widely used to indicate a calm, relaxed, cooperative state brought 
about by the administration of a sedative drug.  The definitions provided in various 
sedation scales used in the studies reviewed demonstrate this well.  A COMFORT scale 
score between 17 and 26 is frequently used to define optimal sedation.  Descriptors in 
that range include drowsy, normal muscle tone, calm, occasional slight movement, heart 
rate at baseline.10 The COMFORT-B scale is derived from the COMFORT score but 
eliminates the physiological parameters of heart rate and blood pressure.  A score of 11-
22 is used to define optimal sedation, and descriptors are similar to the COMFORT 
score.11,12  An SBS score of -1, responsive to gentle touch or voice, or 0, awake and able 
to calm is generally used to describe optimal sedation.  Descriptors in these categories 
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include able to calm with comforting touch or voice when stimulus removed, able to pay 
attention but drifts off after stimulation, occasional movement of limbs or shifting of 
position.  Descriptors in the inadequate sedation range for the SBS include the following: 
does not consistently calm/unable to console, or unsafe (biting endotracheal tube, 
pulling at catheters, cannot be left alone).13 The COMFORT and COMFORT-B 
descriptors include hyperalert, panicky, fights ventilator, coughing, choking, screaming, 
and facial muscles contorted, grimacing.10,11 This depicts a clear and unambiguous 
difference in the state of optimal versus inadequate sedation. 
It is also important to define difficult. The studies reviewed here describe 
treatment failure and persistent under-sedation, and the multiple strategies such as 
adjunctive medications used in an attempt to achieve optimal sedation when describing 
children who are difficult-to-sedate.  Other PICU specific sedation literature supports this 
definition.  The terms “refractory agitation” and “therapy-resistant” are used by van der 
Zwaan et al.14 to describe the use of an alternative drug for sedation in a series of four 
critically ill PICU patients who did not achieve an acceptable level of sedation with usual 
management. 
No studies were undertaken with the purpose of describing the incidence of 
undersedation in critically ill children or the difficult-to-sedate child.  The purpose of the 
studies identified can be grouped into four categories.  These include evaluation of 
sedation drug effectiveness, psychometric testing of sedation assessment instruments, 
comparison of sedation assessment instruments with a more objective measure, and 
evaluation of a sedation protocol.  Multiple instruments were used to assess sedation. 
The definition of over, under and optimal sedation varied between studies, even when 
the same instrument was used. Incidence of undersedation was reported in a variety of 
ways and as a result, there was a wide range of reported incidence of undersedation. 
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Sedation failure was a frequently used term to describe children who were 
difficult-to-sedate, although the definition of the term was not consistent across studies. 
Many studies used reaching the maximum infusion dose of the sedation drug with 
sedation scores remaining in the undersedated range to define difficult-to-sedate 
children.15-17 Studies of sedation assessment instruments generally used being unable to 
maintain sedation scores in the desired range as the definition of undersedation.10-13 One 
study identified inadequate sedation management, defined as two or more hours with an 
SBS score of +1 or +2 despite the provision of appropriate sedation, as an adverse 
event.18   
Two demographic characteristics were identified as possibly typical of difficult-to-
sedate children; Trisomy 2111 and young age.19,20  In general, little information was 
provided about study subjects who were difficult-to-sedate, limiting the ability to identify 
characteristics these subjects have in common. 
Defining Attributes of the Difficult-to-Sedate Child  
 Systematic analysis supports considering the following attributes in a description 
of the difficult-to-sedate child. The child is critically ill and receiving sedation while 
mechanically ventilated. The child is assessed as undersedated despite reaching the 
maximum rate of sedative infusion as outlined in commonly accepted practice 
guidelines. The child requires adjunctive medications due to ongoing sedation scores in 
the undersedated range.  The child is aged birth to 3 years.  The child has a diagnosis of 
Trisomy 21. 
 The attribute of young age is well supported in the pharmacology literature. 
Pharmacokinetics and pharmacodynamics studies carried out in both healthy and 
critically ill pediatric patients show a difference in drug clearance, elimination, and 
response between neonates, infants, children and adolescents.21 Factors related to 
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changes in growth and maturation of organs and physiologic systems drive these 
differences.22,23 de Gast-Bakker et al.24  identified that one to four year old children 
required higher midazolam doses per kilogram of body weight than other age groups.  
Morphine, fentanyl and pentobarbital are other sedation medications affected by both 
age and weight. Critical illness compounds these developmentally driven effects.25 Ince 
et al.26 found decreased midazolam clearance in critically ill children compared with 
pediatric oncology patients receiving procedural sedation and healthy infants receiving 
postoperative sedation. 
 Trisomy 21 as an attribute has limited support. While de Wildt et al.17 describe 
treatment failure in a child with the diagnosis of Down syndrome, Valkenburg et al.27 
found similar COMFORT-B cutoff values when assessing pain and distress in children 
with and without Down syndrome.   
Ista et al.11 also noted that sedation scores trended higher in the day, so unit 
specific practices related to managing the environment, such as quiet time, may also be 
a variable to include. 
Related or Similar but Non-equivalent Concepts 
 There are several concepts related or similar to the difficult-to-sedate child.  
Optimal sedation describes a calm, cooperative child who tolerates the PICU 
environment.  An oversedated child is minimally responsive to the PICU environment 
and may require decreased drug doses.  Procedural sedation involves a single sedation 
episode in order to complete a procedure.  In this case, the goal is usually that the child 
receive short-term sedation which is stopped shortly before or at the time the procedure 
is completed, and the child returns to baseline status.  Many children who receive 
procedural sedation do not require intubation and mechanical ventilation.    
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Agitation is another related concept.  Agitation is usually described in terms of 
physical activity and makes up one element of the sedation assessment scales used 
here, but agitation alone does not define difficult-to-sedate.  Tolerance, or the 
requirement for increasing drug doses over time is also a related but non-equivalent 
concept.  Tolerance develops over time, where the difficult-to-sedate child generally 
requires steady increases in sedation doses beginning shortly after intubation and the 
initiation of mechanical ventilation.  A study by da Silva et al.28 identified that children 
who developed tolerance reached double their initial sedation medication dose between 
days three and five.  Anand et al.29, in a multicenter clinical trial which enrolled 419 
children found that 16% of the study population received double the initial opioid dose by 
day 7, which differs from the trajectory described for children who remained difficult-to-
sedate in the reviewed studies.   
 Another related concept is iatrogenic withdrawal syndrome (IWS).  Agitation and 
restlessness are often seen in children experiencing IWS, and are also some of the 
descriptors of the difficult-to-sedate child.  A systematic review by Best, Boullata, and 
Curley30 described IWS and identified longer duration of therapy and higher cumulative 
dose of benzodiazepines and opioids as the two strongest risk factors for the 
development of IWS.  Children we characterize as difficult-to-sedate receive multiple 
medications at increased doses, putting them at risk for IWS, but IWS develops later in 
the child’s clinical course and the child typically has neurological and gastrointestinal 
symptoms in additional to agitation or restlessness. 
Delirium is also a related concept. The European Society of Paediatric and 
Neonatal Intensive Care (ESPNIC) position statement on assessment of pain, sedation, 
withdrawal and delirium in critically ill infants and children31 clearly demonstrates the 
overlap in presenting signs and symptoms when comparing delirium and the difficult-to-
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sedate child. Delirium is a brain dysfunction, manifested as acute onset of disturbances 
in cognition and consciousness with inattention, altered cognition, and a fluctuating 
course, which develops over time but has an acute onset.31-33  Opioids and 
benzodiazepines have been identified as an underlying cause of delirium in pediatric 
patients.  Three types of delirium have been described in critically ill pediatric patients.  
Hypoactive delirium is the most common presentation and signs and symptoms are the 
opposite of the difficult-to-sedate child.  The child is withdrawn, apathetic, and unable to 
focus or interact. Hyperactive delirium presents as agitation, an inability to focus, and 
inconsolability. The child has altered perception, which may include hallucinations.  The 
severity of the hyperactive behavior fluctuates throughout the day, with the child often 
becoming more agitated in the evening or night.31-33 In contrast, the difficult to sedate 
child is consistently agitated, often hyper alert, with short periods of calm occurring 
directly after the administration of additional sedatives, and appears to respond to the 
environment appropriately. The third type of delirium is identified as mixed, with the child 
fluctuating between a hypoactive and a hyperactive state. As opposed to the difficult-to-
sedate child, this fluctuation is not necessarily related to the administration of sedatives, 
and periods of hypoactivity are variable in length.32  The child who is difficult-to-sedate 
consistently has agitated behavior without altered mental status; actions are purposeful 
and goal directed, such as removal of the endotracheal tube.  In a large multi-center 
point prevalence study of pediatric delirium, Traube et al34 reported that children who 
were in the ICU 3 or more days were more likely to have a diagnosis of delirium.  The 
difficult-to-sedate child generally would require escalating treatment in their first day of 
care.  
Sample Cases 
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 The model case presented here is a composite of many patients described in the 
clinical setting.  Susie is an eighteen-month old who has had a developmentally 
appropriate course. She was admitted to the PICU last night with pneumonia.  She was 
initially managed on non-invasive ventilation but her respiratory failure progressed and 
she required intubation and mechanical ventilation.  Her respiratory status has stabilized.  
The unit has in place a nurse-managed sedation protocol, which includes sedation 
assessment using the SBS at least every four hours and with any sedation infusion 
adjustments, which the nurse implements following the protocol.  Susie was started on 
continuous infusions of midazolam and morphine after receiving bolus doses at the time 
of intubation.  Over the last 8 hours she has required five increases in her midazolam 
infusion and multiple bolus doses, as her SBS score is consistently +1 (restless and 
difficult to calm) to +2 (agitated).  Susie’s mother is at the bedside and is providing 
appropriate soothing strategies.  Susie’s nurse has determined that Susie is not in pain, 
that her intravenous line is patent, and that she is not hypoxic. After Susie sits bolt 
upright in bed which threatens the security of her endotracheal tube, the nurse calls the 
nurse practitioner to the bedside to request an evaluation of Susie’s sedation plan.  
Pentobarbital is ordered and given as an adjunctive medication.  Susie doses off, and 
her nurse and mother breathe a sigh of relief.  Thirty minutes later Susie is again awake 
and agitated, with an SBS score of +1.  In this model case, Susie demonstrates the 
attributes identified through the concept analysis.  On her first day of intubation, Susie’s 
medications are rapidly escalated per the sedation protocol, but she remains agitated.  
She requires adjunctive medications, but does not achieve optimal sedation for more 
than a short time.  There are no underlying causes such as pain or hypoxia that would 
explain her agitation.  Her mother is present at the bedside and providing appropriate 
support.  She does not reach a state of optimal sedation. 
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 A borderline case contains some but not all of the required attributes.  Sam is a 6 
month old admitted from the emergency department to the PICU intubated and 
mechanically ventilated with respiratory failure due to respiratory syncytial virus.  
Morphine and midazolam infusions are begun per protocol.  Sam’s SBS score fluctuates 
between 0 (awake and able to calm) and +1, and he requires bolus doses of midazolam 
about every 2 hours.  He has required one increase in his midazolam infusion in the 
course of a 12 hour shift.  His mother is at the bedside providing appropriate support.  In 
this case, Sam has required a single increase of his infusion, but does not require 
adjunctive medications, and reaches the desired level of sedation for a significant portion 
of the time. 
A related case contains some of the attributes of the identified concept.  John is a 
three year old, admitted to the PICU intubated and mechanically ventilated after 
abdominal surgery.  He is begun on the sedation protocol, and over the course of a 12 
hour shift, his nurse increases his morphine infusion twice, his midazolam infusion once, 
and he receives a total of 9 bolus doses.  John’s SBS score is 0 to -1 (responsive to 
gentle touch or voice), but his pain score is consistently 4 or 5/10, until 20 minutes after 
the second increase in his morphine infusion, when it decreases to 2/10.  In this case, 
increases in the medication infusions were required, as well as additional bolus doses, 
but John did not have an elevated SBS score.  Once his pain was well controlled, he did 
not require further increases.  He also did not require any adjunctive medications. 
Contrary cases are cases that clearly do not represent the concept described, 
and in fact are the opposite of model cases.  For example, Justine is a five year old 
admitted to the PICU with respiratory failure, intubated after failing a trial of hi-flow nasal 
cannula.  She is begun on the sedation protocol, and her first SBS score assessment is -
3 (unresponsive).  Her nurse attributes this to the medications she received to facilitate 
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intubation.  After 4 hours Justine is again assessed, and her SBS score remains -3.  Per 
protocol, the nurse decreases Justine’s midazolam infusion, but her SBS score remains 
-3 to -2 (responsive to noxious stimuli).  Her sedation infusion continues to be decreased 
per protocol until Justine’s SBS score reaches -1.  Justine’s response to the sedation 
medication differed in that she required a much smaller dose than usual, and in fact was 
oversedated for a period of time.  As her infusion dose was decreased she became less 
sedated, but remained in the optimal sedation range.  
These clinical cases all involve PICU patients receiving sedation to facilitate 
mechanical ventilation, but demonstrate each patient’s individual response to sedation.  
Susie, John, and Justine represent different patterns of response to sedation.  Justine is 
oversedated in response to the typical sedation dose, John achieves optimal sedation, 
and Susie represents the difficult-to-sedate child.    
Identify Antecedents and Consequences 
 Antecedents are events that must take place prior to the occurrence of the 
concept.7 A significant antecedent for the difficult-to-sedate child is that the child requires 
sedation for ICU therapies.  Others include a care team knowledgeable about standard 
sedation dosing and administration, a valid and reliable instrument for measuring level of 
sedation, and an identified sedation score goal for the patient.  Another is that no other 
reason exists which could cause the child to remain agitated, for instance hypoxia, 
untreated pain, technology issues such as a malfunctioning IV pump or catheter, or 
incorrectly mixed sedation medication solutions.  Unit culture may be another antecedent 
of this concept.  It is possible that local practices may influence identification of children 
as difficult-to-sedate, as some subjectivity occurs with the use of assessment 
instruments.  Over time, there may be practice drift, and more children may be scored as 
undersedated.  For example, a unit with a high rate of unplanned extubation may 
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interpret any activity as concerning, score children as undersedated and as a result 
increase medication doses, or more readily utilize adjunctive medications. 
As described by Walker and Avant7, consequences are the outcomes of a 
concept.  In the case of the difficult-to-sedate child, having knowledge of this pattern of 
response to sedation therapy might result in earlier treatment, more appropriate drug 
selection, and anticipation and avoidance of adverse outcomes.  It would also guide 
interactions and communication with the family, to help them understand how 
management will be tailored to their child based on the child’s response to therapy.  
There is also the possibility of negative consequences.  If the clinician inaccurately 
identifies the child as difficult-to-sedate, the therapy and care provided may be 
excessive, or an underlying condition such as hypoxia may not be identified and treated.  
This would result in harm the patient.   
Empirical Referents 
 The final step in the concept analysis is defining empirical referents.  Walker and 
Avant7 define empirical referents as ways in which the concept is measured or 
determined.  There are several empirical referents of the difficult to sedate child, and not 
all of them must be present at any one time.  Sedation scores are a primary empirical 
referent.  Empirical referents include other clinical signs and symptoms, for example 
agitation, response to medication, ventilator dysynchrony or inability to achieve the 
target sedation goal despite multiple medication adjustments.  Patient characteristics 
such as age, gender, weight, strength or mobility are also empirical referents.  
Physiologic measures include heart rate and blood pressure, sweating, and response to 
usual therapies administered. 
Operational Definition 
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 As a result of the iterative process of analyzing the concept of the difficult-to-
sedate child this operational definition is provided: the difficult-to-sedate child is 
characterized by a mechanically ventilated critically ill child routinely requiring escalation 
of sedation doses beginning on day one of ICU care, as well as the routine 
administration of adjunctive medications who reaches doses above the standard range 
within the first three days of intubation and remains above the target sedation goal. It is 
likely that this child is young, and possible that the child has a diagnosis of Down 
syndrome.  This classification facilitates prediction of trajectory, selection of appropriate 
therapies on the part of the provider and improved and clinically meaningful outcomes.   
Conceptual Model 
 Themes identified through the literature review point to three types of factors to 
consider in constructing a conceptual model of sedation in the critically ill child.  
Demographic and medical history factors include age, severity of illness, and coexisting 
diagnoses, such as Down syndrome.  Weight or body-mass index, unique genetic code 
and the child’s physiology may also be important as these impact drug distribution and 
clearance.   Factors specific to the environment where care is provided may include unit 
practices related to parent presence and maintaining normal day/night cycles, as well as 
staffing ratios, interrater reliability for sedation assessment instruments used and the 
degree of adherence to sedation protocols.  Factors specific to the process of providing 
and managing sedation include the sedation assessment instrument selected, use of a 
sedation protocol, whether the protocol is nurse-driven, standard and adjunctive 
medications used and local standards for maximum allowable dose.  Figure 2 provides a 
depiction of the model developed. 
Discussion 
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The existing literature does not present a clear operational definition of the 
critically ill, difficult-to-sedate child requiring sedation.  The current literature identifies the 
use of multiple sedation assessment instruments, several of which have not been tested 
for validity or reliability.  Difficult-to-sedate is not consistently defined in the studies 
reviewed, and the incidence of difficult-to-sedate is reported in a variety of ways.  Few 
characteristics of the difficult-to-sedate groups were reported.  It is evident from the 
literature that difficult-to-sedate children are routinely seen in clinical practice, and 
require a different approach to sedation. 
The benefit of identifying difficult-to-sedate children early in their treatment 
course is clear. The clinical manifestations seen in this group of children have an 
immediate impact on the patient, family and clinician.  Sustained periods of agitation 
impact the child’s psychologic and physiologic health.  Parents may feel less confident in 
the care team if they perceive the team is unable to manage their child’s clinical state.   
The goal of identifying children who have the difficult-to-sedate pattern of 
response to sedation is also very much in keeping with the National Precision Medicine 
initiative. The goal of this initiative is to identify which treatments will work best for which 
patients. Stated simply, the goal of precision medicine is to deliver the right treatment to 
the right patient at the right time to facilitate more appropriate, targeted management.35 
Clearly describing the population of children who are difficult-to-sedate could facilitate 
rapidly achieving the targeted sedation goal in this group, by identifying that these 
children need a different sedation approach than the “typical” child and require different 
sedation agents at different doses.  This could also minimize the risk of adverse events 
and the negative effects of excessive sedation medications.   
Future Directions 
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 The model developed identifies several variables appropriate to investigate in 
validating the operational definition of the difficult-to-sedate child.  The validated 
definition can then be used in further studies with the goal of early patient identification, 
early intervention, and the development of effective treatment strategies, both 
pharmacologic and non-pharmacologic.  There is also the opportunity to test the 
economic impact of early identification of the difficult-to sedate child population, as 
caring for these children increases the need for nursing resources, there are increased 
drug costs, and the current management strategies may increase both PICU and 
hospital length of stay.  
 The difficult-to-sedate child describes a patient population that presents 
challenges to the care team, and increases the stress of the child and family at an 
already stressful time.  Studies are needed to validate the characteristics of the difficult-
to-sedate child in order to describe this group of children who consistently demonstrate a 
particular pattern of response to sedation. This would support the development of 
tailored treatment strategies and more effective management. Identifying the 
demographic, physiologic and developmental characteristics associated with differing 
responses to sedation will assist the care team to provide specific and individualized 
sedation strategies for critically ill children.  This goal is in keeping with current, 
innovative research in other areas, which seeks to identify targeted therapies.   
 The next step in moving this work forward will be a survey of PICU clinicians in 
order to establish face and content validity of the factors outlined in the model as 
characteristic of the difficult-to-sedate child.  Those characteristics that are identified as 
valid can then be solidify the proposed operational definition of the difficult-to-sedate 
child clinical phenotype. The proposed clinical phenotype can then be tested 
prospectively and if found to be valid can then be used as the basis for further 
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investigation to establish additional characteristics this group of difficult-to-sedate 
children have in common.  Once the clinical phenotype is well described, a further step 
would be to search for an associated genotype. Clarification of the concept of the 
difficult-to-sedate child identifies that different sedation strategies are needed for 
different subgroups of critically ill pediatric patients.  PICU nurses, as the members of 
the care team who spend the most time with these children, have a vested interest in 
understanding this patient population and play a key role in moving this research 
forward. 
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Table 1: Search Strategy  
• PubMed, EMBASE, Web of Science, SCOPUS, CINAHL, and the Cochrane 
Database of Systematic Reviews and Central Register of Controlled Trials 
were searched.  
• Inclusion criteria: original research on the topic of sedation to facilitate 
intubation and mechanical ventilation in pediatric critical care patients 2 weeks 
to 17 years of age from January 1, 1985 through March 31, 2017.   
• Additional inclusion criteria:  
o level of sedation was measured with a scale 
o the study included a definition of under, over, and optimal sedation.  
o Papers published in languages other than English which had an 
abstract translated into English were screened, and two articles were 
subsequently translated for review.   
• Exclusion criteria: studies focused on dental sedation, procedural sedation, 
perioperative sedation, sedation for comfort care, pain, studies in the neonatal 
intensive care population, and studies including non-intubated patients.  
• Reference lists of articles included in the review were examined to identify 
additional studies for inclusion.  
• A research librarian was consulted to ensure an effective search strategy. 
Search terms: 
1. ventilator* OR ventilation* OR respirator* OR Respiration, artificial OR artificial 
respiration OR Intubation OR endotracheal OR mechanically ventilate OR 
ventil*  OR artificial ventilation  
AND 
 81 
  
 
2. infant* OR neonate* OR newborn* OR pediatric OR paediatric OR child OR 
children OR teen* OR adolescent* OR youth OR juvenile  
AND 
3. sedation quality* OR quality of sedation OR sedation level OR level of sedation  
       AND 
4. pediatric critical care OR paediatric critical care OR paediatric intensive care 
OR pediatric intensive care OR PICU  
       AND 
5. measur* OR evaluat* OR tool* OR battery OR instrument* OR inventor* OR 
checklist OR indicator OR score* OR scoring OR questionnaire OR series OR 
scale* OR protocol* OR appraisal OR assessment OR behavior* OR guideline 
OR algorithm OR sedation scale OR sedation assess* OR sedation protocol  
AND 
6. nurs* OR  nursing assess* OR nursing assessment  
AND 
7. pharmacodynamic OR sedat* OR midazolam OR lorazepam OR diazepam OR 
benzodiazepine* OR fentanyl OR remifentanil OR morphine* OR ketamine OR 
dexmedetomidine OR clonidine OR pentobarbital OR opioid* OR propofol OR 
hypnotic OR depressant OR narcotic* OR *drug therapy OR drug utilization 
 
 
 
 
 82 
  
 
Table 2: Studies Evaluated 
Study Site Design/Testing Sample Size Age Sedation 
Assessment Scale 
Under, over, optimal 
Sedation Definition 
Undersedation 
Incidence (%) 
Dreyfus et al 
(2017)36 
PICU 
France 
Prospective 
observational 
 
Sedation 
protocol 
n= 200 0 to 18 
years 
COMFORT-B Under >17 
Optimal 11-17 
Over <11 
4% pre-protocol 
8% post-protocol 
 
Gaillard-Le 
roux et al 
(2017)37 
PICU 
France 
Prospective 
observational 
 
Sedation 
protocol 
n= 194 28 days to 
18 years 
COMFORT-B Target 1 
Under >17 
Optimal 11-17 
Over <11 
Target 2 
Under >11 
Optimal 8-11 
Over <8 
Not reported 
Beytut et al 
(2016)38 
PICU 
Turkey 
Prospective 
observational 
 
Sedation 
protocol 
n = 37 2 to 9 
years 
COMFORT Under >26 
Optimal 17-26 
Over <17 
Not reported 
da Silva et al 
(2016)28 
PICU 
Brazil 
Pragmatic RCT 
 
Drug 
n = 112 3 to 14 
months 
COMFORT-B Under >22 
Optimal 11-22 
Over <11 
 
257 episodes of 
agitation reported 
Curley et al 
(2015)15 
PICUs 
US 
RCT 
 
Sedation 
protocol 
n= 2449 2 weeks 
to 17 
years 
SBS Under +1/+2 
Optimal -1/0 
Over -3/-2 
547 events SBS +1/+2 for 
2 hours despite 
treatment 
Neunhoeffer 
et al  
(2015)39 
PICU 
Germany 
Non-
randomized 
intervention 
trial 
n = 172 0 to 18 
years 
COMFORT-B 
NISS 
COMFORT-B 
Under >22  
Optimal 12-18  
Over <12 
COMFORT-B 
2168 observations 
18% 
NISS 
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Sedation 
protocol 
NISS 
Under 1 
Optimal 2 
Over 3 
2168 observations 
11% 
Wolf et al 
(2014)17 
PICUs 
UK (10) 
RCT 
 
Drug 
n = 125 1 month 
to 15 
years 
COMFORT Under >26 
Optimal 17-26 
Over <17 
 
Treatment failure 
19/125 
(15.2) 
Percent of time 
undersedated 0-54 
Silva et al 
(2013)40 
PICU 
Brazil 
Prospective 
observational 
 
BIS monitor 
n = 11 1 month 
to 16 
years 
COMFORT-B COMFORT-B 
Under >23 
Optimal 11-23 
Over <11 
BIS 
Under >80 
Optimal 40-79 
Over <40 
COMFORT-B 
5.7-11.5% 
BIS 
14.3% 
Amigoni et 
al (2012)41 
PICU 
Italy 
Prospective 
observational 
 
BIS monitor 
n = 46 Birth to 6 
years 
COMFORT-B COMFORT-B 
Under >22 
Optimal 11-22 
Over <11 
BIS 
Under >80 
Optimal 40-80 
Over <40 
COMFORT-B 
0 
BIS 
2/46 
(4.3) 
Ista et al 
(2009)42 
PICU 
The 
Netherlands 
Non-
randomized 
intervention 
trial 
 
n = 131 0 to 3 
years 
COMFORT-B 
NISS 
COMFORT-B 
Under >22 OR 11-22 
with NISS 1 
Optimal 11-22 with 
NISS 2 
Over <11 
461/3573 observations 
identified as 
undersedated (12.9) 
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Sedation 
protocol 
OR 11-22 with NISS 3 
NISS 
Under 1 
Optimal 2 
Over 3 
Darnell et al 
(2008)43 
PICU 
US 
RCT 
 
Drug 
n = 72 1 day to 
18 years 
MMAAS Under +3 
Optimal +2 to -2 
Over -3 
Reported mean number 
of times subjects 
undersedated without a 
denominator: 
16.7 naloxone group, 
14.6 placebo group.  
Bustos Bu et 
al (2007)44 
PICU 
Chile 
Prospective 
observational 
 
BIS monitor 
n = 9 9 months 
to 14 
years 
COMFORT Under >26 
Optimal 17-26 
Over <17 
7/90 BIS observations 
(7.8) 
Curley et al 
(2006)13 
PICUs 
US 
Prospective 
observational 
 
Sedation Scale 
metrics 
n = 91 6 weeks 
to 6 years 
SBS Under +1/+2 
Optimal -1/0 
Over -3/-2 
8/198 
(4) 
De Wildt et 
al (2005)11 
PICU 
The 
Netherlands 
Prospective 
observational 
 
Drug 
n = 21 2 days to 
17 years 
COMFORT Under >26 
Optimal 17-26 
Over <17 
14/242 episodes of 
COMFORT score > 26 
(5.8) 
Note: Could not reach 
target sedation in one 
patient with Trisomy 21 
Ista et al 
(2005)14 
PICU 
The 
Netherlands 
Prospective 
observational 
 
Sedation Scale 
metrics 
n = 78 Birth to 18 
years 
COMFORT-B 
NISS 
COMFORT-B 
Under >22 
Optimal 11-22 
Over <11 
NISS 
Under 1 
Optimal 2 
Over 3 
93/843 (11) 
 
Note: Daytime scores 
consistently higher 
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Triltsch et al 
(2005)45 
PICU  
Germany 
Prospective 
observational 
 
BIS monitor 
n = 40 3 weeks 
to 16 
years 
COMFORT 
 
COMFORT 
Under >26 
Optimal 17-26 
Over <17 
 
0/40 
(0) 
Twite et al 
(2005)5 
PICU 
US 
Prospective 
observational 
 
BIS monitor 
n = 75 1 month 
to 12 
years 
COMFORT BIS 
Under >80 
Optimal 61-79 
Over <61 
9.5% of observations 
Arenas-
Lopez et al 
(2004)10 
PICU 
UK 
Prospective 
observational 
 
Drug 
n = 14 1 month 
to 3 years 
COMFORT COMFORT 
Under >23 
Optimal 13-23 
Over <13 
110/1022 hours  
(10.8) 
Treatment failure 3/24 
(12.5) 
Tobias & 
Berkenbosch 
(2004)46 
PICU  
US 
RCT 
BIS monitor 
 
Drug 
n = 30 2 months 
to 8 years 
Ramsay 
BIS 
Ramsay 
Under 1 
 
12/30 subjects had at 
least one episode of 
undersedation 
Total number of 
episodes not provided 
Aneja et al 
(2003)47 
PICU  
US 
Prospective 
observational 
 
BIS monitor 
n = 48 3 months 
to 18 
years 
Ramsay 
 
Under 1 
Optimal 2-5 
Over 6 
42/458 observations 
(9.2) 
Courtman et 
al (2003)48 
PICU UK Prospective 
observational 
 
BIS monitor 
n = 43 1 month 
to 16 
years 
COMFORT 
BIS 
 
BIS 
Under >80 
Optimal 40-80 
Over <40 
49/373 observations 
(13.1) 
Alexander et 
al (2002)49 
PICU 
Canada 
Retrospective 
observational 
 
Sedation 
protocol 
n = 10 children COMFORT Under >18 
Optimal 14-18 
Over <14 
11/14 episodes 
(78.6) 
Berkenbosch 
et al 
(2002)50 
PICU  
US 
Prospective 
observational 
 
n = 24 1 month 
to 20 
years 
PICU scale 
Tracheal 
suctioning scale 
Ramsay 
Under 1 
Optimal 2-4 
37/426 observations 
(8.7) 
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BIS monitor  Over 5-6 
 
Crain et al 
(2002)51 
PICU 
US 
Prospective 
observational 
BIS monitor 
n = 31 1 month 
to 5 years 
COMFORT 
 
COMFORT 
Under >26 
Optimal 17-26 
Over <17 
BIS 
Under >80 
Optimal 40-80 
Over <40 
 
5/62 observations 
(8.1%) 
Ambrose et 
al 
(2000)9 
PICU 
UK 
Prospective 
observational 
 
Drug 
n = 30 1 day to 3 
years  
0 – 10 sedation 
scale 
Under <2 
Optimal 2-7 
Over >7 
2/30 treatment failure 
(6.7) 
Playfor et al 
(2000)52 
PICU  
UK 
Prospective 
observational 
 
Drug 
n = 28 1 month 
to 16 
years 
Ratcliff scoring 
system 
 
1, 2, 4 = acceptable 
3, 5 = unsatisfactory 
8/81 observations (9.8) 
Brunow de 
Carvalho et 
al (1999)53 
PICU 
Brazil 
Prospective 
observational 
 
Sedation Scale 
metrics 
n = 18 2 weeks 
to 5 years 
COMFORT 
Hartwig 
COMFORT 
Under >26 
Optimal 17-26 
Over <17 
Hartwig 
Under >18 
Optimal 15-18 
Over <15 
COMFORT 
2/30  
(6.7) 
Hartwig 
5/30  
(16.7) 
Parkinson et 
al (1997)16 
PICU 
UK 
RCT 
 
Drug 
n = 43 0 to 15 
years 
1 – 5 descriptive 
scale 
Under 3, 5  
Optimal 2, 4  
Over 1 
294/799 observations 
(36.8) 
Treatment Failure 2/43 
(4.7) 
Reed et al 
(1996)54 
PICU  
US 
Non-
randomized 
n = 28 1 week to 
15 years 
COMFORT Under >26 
Optimal 17-26 
Over <17 
5/28 subjects 
(17.9) 
 87 
  
 
intervention 
trial 
 
Drug 
Marx et al 
(1994)3 
PICU 
US 
Prospective 
observational 
 
Sedation Scale 
metrics 
n = 85 0 to 8 
years 
COMFORT 
 
Descriptive scale 
 
COMFORT 
Under >26 
Optimal 17-26 
Over <17 
Descriptive 
Inadequately 
sedated = 3 
Too sedated = 1 
COMFORT 
14/110 observations 
(12.7) 
Descriptive 
18/110 observations 
(16.4) 
Arnold et al 
(1993)55 
PICU 
US 
Prospective 
observational 
Drug 
n= 10 3 weeks 
to 19 
years 
Clinical Sedation 
Score 
Under 1 
Optimal 2-5 
Over 6 
21% of total 
administration time 
Rosen & 
Rosen 
(1991)56 
PICU 
US 
Retrospective 
observational 
 
Drug 
n = 55 Birth to 19 
years 
Five point activity 
scale 
Under > 3 
Optimal 2-3 
Over 1 
 
<10% of total infusion 
time 
BIS = bispectral index; COMFORT = Comfort scale; COMFORT-B = COMFORT behavioral scale; MMAAS = Modified Motor Activity Assessment 
Scale;   NISS = Nurse Interpretation of Sedation Scale; RCT = randomized controlled trial; SBS = State Behavioral Scale; UK = United Kingdom; US = 
United States.
 88 
  
 
Figure 1: PRISMA Flow Diagram 
PRISMA Flow Diagram 
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Box 1: Sequential Steps in the Walker & Avant Method of Concept Analysis 
1. Identify the concept for analysis; the phenomenon of interest 
2. Determine the aims of the analysis, such as clarify the meaning of a concept or 
create an operational definition 
3. Identify all uses of the concept, including dictionary definitions and use of the 
concept in fields other than nursing 
4. Review all uses identified to determine the concept’s defining attributes; 
characteristics that appear consistently in all sources reviewed 
5. Identify related or similar, but non-equivalent concepts 
6. Identify a model case; a “real world” case that includes all defining attributes 
7. Identify borderline (many but not all defining attributes are present), related (a 
few of the defining attributes are present), and contrary (cases that are the 
opposite of the described concept) 
8. Identify antecedents (events that must occur prior to the concept occurring) 
and consequences of the concept 
9. Identify empirical referents (how a concept is measured or determined) 
Walker, L.O., & Avant, K.C. (2011). Strategies for theory construction in nursing. (5th 
ed.). Boston, MA: Prentice Hall. 
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Figure 2: Conceptual Model  
 
 
91 
  
 
CHAPTER 3 
Face and Content Validity of Variables Associated with the Difficult-to-Sedate 
Child in the Pediatric Intensive Care Unit: A Survey of Pediatric Critical Care 
Clinicians 
 
Ruth M. Lebet, RN, MSNa 
PhD Student 
aUniversity of Pennsylvania School of Nursing 
418 Curie Boulevard - #423B 
Philadelphia, PA 19104-4217 USA 
lebet@nursing.upenn.edu   
 
Lisa A. Asaro, MSb 
Biostatistician 
Department of Cardiology 
bBoston Children’s Hospital 
300 Longwood Avenue 
Boston, MA 02115 USA 
lisa.asaro@cardio.chboston.org 
 
Athena F. Zuppa, MD, MSCEc, d 
Associate Professor, Anesthesiology and Critical Care 
Director, Center for Clinical Pharmacology 
Associate Director, Pediatric Critical Care Fellowship Program 
cThe Children's Hospital of Philadelphia 
dPerelman School of Medicine 
University of Pennsylvania 
34th & Civic Center Boulevard 
Suite 9329 
The Children’s Hospital of Philadelphia 
Philadelphia, PA 19104 USA 
ZUPPA@email.chop.edu 
 
Martha A.Q. Curley, RN, PhD, FAANa, d 
Ellen and Robert Kapito Professor in Nursing Science 
aSchool of Nursing 
Anesthesia and Critical Care Medicine 
dPerelman School of Medicine 
University of Pennsylvania 
418 Curie Boulevard - #425 
Philadelphia, PA 19104-4217 USA 
curley@nursing.upenn.edu   
 
 
92 
  
 
 
This work was performed at the University Of Pennsylvania School Of Nursing. 
Corresponding author: Ruth Lebet, RN, MSN; University of Pennsylvania School 
of Nursing; 418 Curie Boulevard - #423B; Philadelphia, PA 19104-4217; 
lebet@nursing.upenn.edu 
Key words: child; infant; intensive care; critical care; sedation; surveys and 
questionnaires 
  
 
 
93 
  
 
Abstract  
Background: Clinicians recognize that some critically ill children are difficult-to-
sedate.  It may be possible to identify this unique clinical phenotype for sedation 
response using statistical modeling techniques adopted from machine learning.  
This requires identification of a finite number of candidate variables to include in 
the statistical model.  
Objective: To establish face and content validity for 17 candidate variables 
identified in the literature as characteristic of the difficult-to-sedate child 
phenotype.   
Methods: Pediatric critical care clinicians rated the relevance of 17 candidate 
variables characterizing the difficult-to-sedate child using a four-point scale 
ranging from not (1) to highly relevant (4).  Face and content validity of these 
variables were assessed by calculating a mean score for each item and 
computing an item-level content validity index.  Any item with a mean score >1 
was rated as having adequate face validity.  An item-level content validity index 
≥0.70 indicated good to excellent content validity.  
Setting and Participants: Web-based survey emailed to members of the Pediatric 
Acute Lung Injury & Sepsis Investigators Network or the Society of Critical Care 
Medicine Pediatric Sedation Study Group. 
Results: Of 411 possible respondents, 121 useable surveys were returned for a 
response rate of 29%.  All items had a mean score >1, indicating adequate face 
validity.  Ten of 17 items scored an item-level content validity index ≥0.70.  The 
highest scoring items were requiring three or more sedation classes 
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simultaneously, daily modal sedation score indicating agitation, sedation score 
indicating agitation for 2 consecutive hours, receiving sedatives at a dose >90th 
percentile of the usual starting dose and receiving intermittent paralytic doses for 
sedation. 
Conclusions: Computation of an item-level content validity index validated 
candidate variables to include in statistical modeling of the difficult-to-sedate 
phenotype.  The results indicate consensus among pediatric critical care 
clinicians that the majority of candidate variables identified are characteristic of 
the difficult-to-sedate child. 
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Introduction 
Each year, more than 115,000 critically ill children receive sedation to help 
them tolerate intubation and mechanical ventilation.1   A substantial number of 
these children do not respond as expected to appropriately dosed sedation and 
remain agitated for some period of time, leading to iatrogenic injury and 
increased stress.2-5  These children, who remain agitated despite receiving usual 
doses of sedation, or who eventually reach their target sedation goal but require 
much larger amounts of sedative drugs, are considered by the clinical team to be 
difficult-to-sedate. Little is known about the reasons contributing to this 
phenomenon in these children, preventing early identification of the child who will 
be difficult-to-sedate.  The child is often identified as difficult-to-sedate at the time 
care providers are actively administering sedative drugs, resulting in a delay in 
the attainment of therapeutic concentrations and the desired clinical effect.  This 
experience causes excessive and potentially avoidable burden on the child and 
family, and increases the chances that the child’s safety has been compromised, 
and injury may have occurred.  Developing a mechanism to identify the difficult-
to-sedate child could allow for early identification, and prepare the care provider 
with a priori knowledge that the child may require more than the typical sedation 
needs.  However, the first step towards the goal of early identification is 
consensus on the characteristics defining the difficult-to-sedate child. 
Background 
Many factors hamper identification of the difficult-to-sedate child.  
Sedation in the pediatric intensive care unit (PICU) is a complex phenomenon, 
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impacted by multiple variables.  Easily implemented, valid and reliable 
instruments that describe sedation levels in children have only become available 
and widely used in the last decade.6,7  Patients cared for in the PICU vary widely 
in age and encompass enormous physiological and psychosocial differences.  
Although well-studied in adults, there are limited data on the metabolism and 
elimination of drugs commonly used for sedation in critically ill children.8,9 Organ 
maturation and critical illness affect the rate at which sedation medications are 
distributed, metabolized and eliminated from the body.  The influence of 
psychosocial development in response to sedation is not thoroughly described.  
There may be a genetic basis for the difficult-to-sedate child, due to 
polymorphisms in the genes that encode drug metabolizing enzymes as well as 
pertinent receptors.3,10 Finally, each PICU’s individual sedation management plan 
dictates how and when sedation is delivered, the specific agents and doses used 
to provide sedation, as well as the definition of optimal levels of sedation.  These 
factors contribute to the challenge of studying sedation in critically ill children. 
Defining sedation-related clinical phenotypes in critically ill children would 
facilitate better clinical management of these patients while decreasing potential 
harm.  Specifically, insight into an individual child’s response to sedation would 
allow the selection of personalized therapy and potentially contribute to improved 
clinical outcomes.  Phenotype identification supports treatments geared to the 
needs of individual patients by considering each individual’s unique genetic, 
biomarker, phenotypic or psychosocial characteristics that distinguish them from 
other patients with similar presentations.11  High doses of sedatives and the 
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simultaneous use of multiple sedative agents, as typically occurs in the difficult-
to-sedate child, generally results in adverse effects such as hypotension, 
bradycardia, propofol infusion syndrome and iatrogenic withdrawal syndrome.12  
Based on recent evidence that prolonged or repeated use of sedative and 
anesthetic drugs may negatively affect the developing brain by causing brain cell 
death, the United States Food and Drug Administration has required a warning 
be added to drug labels indicating that brain development in children three and 
under may be affected by exposure to these drugs.  Included in this group are 
some of the most commonly used pediatric sedation drugs including midazolam, 
lorazepam, pentobarbital, ketamine and propofol.13 Identifying and providing 
targeted sedation strategies most effective for the difficult-to-sedate child could 
minimize these effects. 
An operational definition of the difficult-to-sedate child clinical phenotype 
does not exist.  In other populations, advanced statistical methods including 
cluster, classification and regression tree, and latent class analysis have been 
used to analyze large datasets and create an operational definition of specific 
phenotypes within a disease process such as childhood asthma, pediatric sepsis 
or acute respiratory distress syndrome.14-16 These statistical methods require 
identification of candidate variables likely to be associated with the concept under 
investigation.  In the case of intubated and sedated children, the difficult-to-
sedate child clinical phenotype might include a combination of demographic, 
physiologic, genetic and developmental factors.17-19 
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We sought to create an operational definition of the difficult-to-sedate 
clinical phenotype using a large data set from the Randomized Evaluation of 
Sedation Titration for Respiratory Failure (RESTORE) study (clinicaltrials.gov 
identifier: NCT00814099).20 This data set of 2,449 children with acute respiratory 
failure contains hundreds of variables and millions of data points, requiring a 
thoughtful approach to identifying candidate variables.  Completion of a concept 
analysis using the methodology described by Walker and Avant21 was the first 
phase in identifying candidate variables from those available in the RESTORE 
database.  
The next phase in creating our operational definition involved assessing 
face and content validity of the candidate variables identified in order to 
substantiate their appropriateness and ensure all possible candidate variables 
were included.  Face and content validity are generally used in instrument 
assessment.  Face validity assesses whether an instrument seems to measure 
what it purports to measure.  It assesses the relevance of an item to a construct 
in the opinion of experts.22 Content validity is generally used to assess whether 
the content of an instrument is inclusive and representative of the domain of 
interest; i.e., do the items completely measure the domain.23-25 Polit and Beck25 
note that content validity assesses if the items in the tool, when considered as a 
group, provide a reasonably complete operational definition of the construct 
being measured.  Although not intended to be a formal instrument for repeated 
use, our survey was constructed to include what we had identified as the 
characteristics of the difficult-to-sedate child phenotype.  Here we report on the 
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face and content validity of candidate variables potentially characteristic of the 
difficult-to-sedate phenotype in children based on our survey of expert pediatric 
critical care clinicians. 
Methods 
Design and Data Collection 
This study consisted of a web-based survey sent to a purposive sample of 
experts, practicing pediatric critical care providers, and is described here using 
the Checklist for Reporting Results of Internet E-Surveys (CHERRIES).26 The 
survey link was sent via e-mail to all members of the Pediatric Acute Lung Injury 
& Sepsis Investigators (PALISI) network and to all members of the Society of 
Critical Care Medicine (SCCM) Pediatric Sedation Study Group.  These groups 
were chosen because members are practicing critical care clinicians with 
extensive experience in pediatric critical care and sedation.  PALISI members are 
clinical researchers from PICUs across North America who collaborate to 
conduct multi-center research studies concerning pediatric critical illness, with a 
focus on interventions and outcomes.27 Members of the SCCM Pediatric 
Sedation Study Group are critical care clinicians from the United States with a 
strong interest in pediatric sedation and knowledge of best practices.  The 
group’s primary charge is to develop guidelines related to pediatric sedation.  
The Institutional Review Board of the University of Pennsylvania reviewed the 
study and determined it to be exempt from full board review.  No personal 
information was collected and data was stored on a password-protected drive, to 
which only the investigators had access.  
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As described above, we developed the list of candidate variables included 
in the survey through a literature review and concept analysis.  A pediatric critical 
care nurse scientist and a pediatric intensivist reviewed an initial draft of the 
survey for clarity and completeness.  Prior to deployment, the research team 
tested the technical functionality of the survey, which used the Qualtrics 
(Washington, DC, USA) survey platform.  In order to avoid coercion and ensure 
anonymity, the PALISI Network Coordinator and SCCM Quality and Guidelines 
Specialist forwarded an email containing an introduction, instructions and the 
survey link (Appendix A) to their membership.  A unique survey link was set up 
for each group in order to better describe participants.  The survey link was sent 
to 389 PALISI members, representing 78 centers on April 6, 2015, with reminder 
emails sent one and two weeks later.  SCCM task force members (24 members 
representing 14 centers) received the initial email on April 22, 2015, with a 
reminder sent one week later.  Two individuals were members of both groups 
and received both sets of emails.  The survey was closed to responses on May 
8, 2015. 
The survey (Appendix B) was a voluntary, self-administered web-based 
survey consisting of five screens in total, including an introductory page, a page 
displaying questions concerning 17 candidate variables and an “Other (please 
list)” free-text question, a respondent demographics page, a page with a single 
free-text question, and a final thank you page.  The first question in the SCCM 
survey asked if the respondent had previously completed the survey.  A “yes” 
response closed the survey.  There were no mandatory items.  To encourage 
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initial participation, an estimate of the time required for survey completion (“a few 
minutes”) was included in the introductory text.  To encourage continued 
participation once started, a progress bar at the bottom of the screen displayed 
the participant’s progress, along with text indicating percent completed.  Forward 
and back buttons allowed respondents to review and change their answers prior 
to survey submission.  The survey platform captured all responses entered, even 
if the full survey was not completed.  To provide context, respondents were 
instructed to answer each question in relation to a patient’s first four days of 
endotracheal intubation, assuming that the patient’s pain was adequately 
controlled and that sedation medication doses were appropriate.  Each item 
related to the candidate variables was scored as not (1), somewhat (2), quite (3) 
or highly (4) relevant in identifying the difficult-to-sedate phenotype. 
Data Analysis  
 Data was downloaded from the survey management site to a password-
protected drive as an Excel spreadsheet and was analyzed using IBM SPSS 
Statistics 24 (IBM, Armonk, NY, USA).  Thirteen surveys (11 from PALISI and 2 
from SCCM respondents) which were opened but had no data entered were 
deleted during data cleaning.  All surveys with any data concerning 
characteristics of the difficult-to-sedate child were included in the analysis, even if 
they were incomplete.  Descriptive analysis of the two respondent demographic 
questions consisted of calculation of frequencies and percentages.  In order to 
determine face validity, we calculated the mean score for each item.  A mean 
score greater than 1 was considered an indicator of acceptable face validity.  We 
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also calculated an item-level content validity index (I-CVI) for each candidate 
variable.  The I-CVI is a way to measure interrater agreement of each item in an 
instrument, and to identify items that should be retained or deleted from the 
instrument.  In order to calculate the I-CVI, the number of experts who ranked an 
item as quite or highly relevant is divided by the total number of experts.21 A 
threshold of 0.70 (at least 70% of respondents rated these items as quite (3) or 
highly (4) relevant) was considered an indication of good to excellent content 
validity for the item. In order to ensure accuracy and account for missing data, we 
used the number of complete responses to the item as the denominator in our 
calculations.   
Results 
One hundred twenty-one clinicians, 113 (95%) physicians, 3 (2%) 
advanced practice nurses, 4 (3%) nurse scientists and 1 (<1%) respiratory 
therapist responded to the survey sent to 411 individuals for a response rate of 
29%.  Table 1 provides further detail about response rates and sample 
demographics.  Of the 89 clinical sites represented by PALISI and SCCM groups, 
members from 61 sites (69%) responded, with a mean of 1.6 individuals per site 
(range of 1 to 4) completing the survey.  Twelve of 17 items related to candidate 
variables had a 100% response rate, four had 99%, and one item had a 98% 
response rate.  Six of 2,040 data points related to the candidate variables were 
missing, resulting in a missing data rate of 0.3%.  All variables had a mean score 
>1, ranging from 1.5, midway between not and slightly relevant, to 3.5, midway 
between quite and highly relevant.  Table 2 summarizes the I-CVI for each item.  
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Ten of seventeen items met the threshold of 0.70.  Those items include requiring 
three or more sedation classes simultaneously, a daily modal State Behavioral 
Scale (SBS) score indicating agitation (SBS +1/+2), an SBS score indicating 
agitation for 2 consecutive hours, receiving sedatives at a dose >90th percentile 
of the usual starting dose, receiving intermittent paralytic doses for sedation, 
suspected delirium, unplanned endotracheal extubation, unplanned removal of 
an invasive device, paradoxical response to sedation, and Trisomy 21.  At 0.65, 
the I-CVI for the item previous sedation exposure did not quite meet the 
threshold.  The six items which had a low I-CVI were all demographic or 
diagnostic characteristics, including not able to verbally communicate, body mass 
index >90th percentile, an oncologic diagnosis, moderate or severe cerebral 
disability, moderate or severe overall disability, and bronchiolitis.   
Responses from the PALISI and SCCM groups were similar.  This would 
be expected as the members of both groups are practicing clinicians with 
experience in pediatric sedation, and the SCCM group was added to increase the 
pool of experts.  Two items which met the I-CVI threshold in the PALISI group 
were just under 0.70 in the SCCM group (both 0.67), paradoxical response to 
sedation and sedation doses >90th percentile of the usual starting dose.  The 
highest-rated item for both groups was requiring three or more sedation classes 
simultaneously.  The SCCM group ranked suspected delirium and unplanned 
endotracheal extubation second and third.  The PALISI group ranked daily modal 
SBS indicative of agitation and SBS indicative of agitation for two consecutive 
hours second and third.  The results for the six items which clearly did not meet 
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the I-CVI threshold were ranked in the same order by both groups, and each of 
these items had an I-CVI <0.50. 
Several respondents identified characteristics not listed.  Table 3 
summarizes the 17 responses provided when the “Other (please list)” option was 
selected for the question “Typically has the following 
demographics/diagnoses/characteristics”.  Young age was listed as a 
characteristic by 5 respondents, the remaining characteristics were identified by 
single respondents.  Table 3 also summarizes the 61 free-text responses listing 
other criteria characterizing the difficult-to-sedate child.  Twelve respondents 
identified age ≤4 years, 8 identified multiple drugs/bolus doses, 5 identified 
medical diagnosis, sleep/day-night cycling issues or psychiatric diagnosis, and 
anxious parents and rapid change in sedation level were each identified by 4 
respondents. 
Discussion  
There is currently no operational definition of the difficult-to-sedate child in 
the pediatric critical care literature.  This study assessed face and content validity 
of candidate characteristics, derived from a literature review and concept 
analysis, to be used in constructing an operational definition of the difficult-to-
sedate child phenotype.  The majority of items met the threshold we set for good 
to excellent content validity.  The items that did not were all related to 
demographic or diagnostic characteristics, and the mean scores for these items 
were in the somewhat relevant range. The results support including all candidate 
variables evaluated in this survey when developing the model in the next phase 
 
 
105 
  
 
of our project, as all variables had a mean score >1, indicating adequate face 
validity.  
Because content validity also considers whether all important elements of 
a domain are represented, we were particularly interested in the number of 
additional characteristics identified in the free-text responses.  A few 
characteristics were consistently identified, including young age, sleep or 
day/night cycling issues, requiring multiple bolus doses, a psychiatric diagnosis 
or parental anxiety.  Although not all of these variables were measured in the 
RESTORE data set, those that were measured such as age, received medication 
to facilitate sleep, received medication to treat delirium, received multiple bolus 
doses and medical diagnosis will be added to the list of candidate variables to be 
evaluated in the next phase of this project. 
In general, there was remarkable consistency between the PALISI and 
SCCM responders, despite the small number of respondents and small 
population of the SCCM group.  Aside from organizational affiliation, there was 
minimal missing data, which further supports the consistency of the findings.  No 
single center was over-represented in the sample, so it is unlikely that responses 
were skewed by regional differences such as differing patient populations or local 
sedation practices. 
 As with any survey, several factors may have introduced bias.  The survey 
was voluntary and participants self-selected, so the results may represent the 
viewpoint of clinicians who have a specific point of view related to this topic.  The 
sample population was drawn from a research network and an expert sedation 
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workgroup, and may not be representative of the PICU clinician population in 
general.  It is also possible that a respondent from either of the groups, who only 
received one invitation to complete the survey, may have taken the survey 
multiple times or that the two individuals who were members of both groups and 
received two invitations may have taken the survey more than once.  We 
collected minimal respondent demographic data and respondents were not 
assigned any type of identifier, so there was no way to identify multiple surveys 
from a single individual.  Because the survey link was sent via email, it is also 
possible that the link may have been provided to an individual not included in the 
original sample frame. We attempted to prevent this by including a request that 
the survey link not be forwarded in the email sent to the SCCM group, but did not 
include this in the PALISI email request.  Although no respondent listed an 
organization not included in the PALISI or SCCM lists provided by those 
organizations, 16% of respondents did not identify their organization.  Finally, 
95% of the respondents were physicians.  Nurses, who are consistently at the 
bedside, may have a different perception of the characteristics of the difficult-to-
sedate child.  It would be interesting to solicit the expert opinion of this group of 
providers, to see if any additional characteristics are identified. 
Conclusions 
This survey asked practicing clinicians to assess whether the items identified 
through a theoretical concept analysis agreed with their practice experience.  The 
results of this survey indicate consensus among expert PICU clinicians, primarily 
physicians, that the items included in this survey are consistent characteristics 
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exhibited by the child who is difficult-to-sedate.  They will be used in phase three 
of this project to create a statistical model of the difficult-to-sedate child 
phenotype.  Additional characteristics identified by the expert panel will also be 
added to the list of candidate variables to be included in the model.  Developing a 
mechanism to prospectively identify the difficult-to-sedate child would allow 
sedation tailored to the individual child, avoiding the burden placed on the child 
and family and decreasing the potential for injury.  
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Table 1. Survey Response Details 
 Total 
n (%) 
PALISI 
n (%) 
SCCM 
n (%) 
Center Representation1 61/89 (69)2 59/78 (76) 7/14 (50) 
Respondents 121/411 (29)3 112/389 (29) 9/24 (39) 
Role4     
Attending Physician 115 (95) 106 (95) 9 (100) 
Advanced Practice 
Nurse 
3 (3) 3 (3) 0 
Nurse Scientist 2 (2) 2 (2) 0 
Respiratory Therapist 1 (<1) 1 (<1) 0 
PALISI, Pediatric Acute Lung Injury & Sepsis Investigators; SCCM, Society for 
Critical Care Medicine.  
1 Nineteen of 121 respondents (16%) did not indicate organizational affiliation. 
2 Due to overlap in organizations represented by PALISI and SCCM members, 
total center representation does not equal the sum of PALISI plus SCCM center 
representation. 
3 Two potential respondents were members of both the PALISI and SCCM 
groups, so number of total possible respondents does not equal the sum of 
PALISI plus SCCM respondents. 
4 Pediatric ICU Fellow (physician-in-training), Research Assistant, and 
Pharmacist were other options but none participated. 
  
 
 
114 
  
 
Table 2. Difficult-to-Sedate Criteria: Mean Score and Item-level Content 
Validity Index (I-CVI)  
 Mean 
Score 
Total 
 
Total 
I-CVI 
PALISI 
 
SCCM 
 (n=121) (n=121) (n=112) (n=9) 
Sedation Characteristics      
Requires 3 or more sedation 
classes simultaneously 
3.51 
 
0.93 
(112) 
0.92 
(103) 
1.00 
(9) 
Daily modal SBS +1/+2  3.211 0.82 
(98)1 
0.83 
(92)2 
0.75 
(6)3 
SBS +1/+2 for 2 consecutive 
hours 
3.094 0.79 
(95)4 
0.80 
(89) 
0.75 
(6)3 
Doses >90th percentile of usual 
starting dose 
3.244 0.78 
(93)4 
0.78 
(87)2 
0.67 
(6) 
Intermittent paralytic doses for 
sedation 
3.13 0.74 
(90) 
0.74 
(83) 
0.78 
(7) 
Sedation-related Events     
Suspected delirium  3.15 0.79 
(95) 
0.78 
(87) 
0.89 
(8) 
Unplanned endotracheal 
extubation 
3.13 0.72 
(87) 
0.71 
(79) 
0.89 
(8) 
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Unplanned removal of an 
invasive device 
3.13 0.71 
(86) 
0.71 
(79) 
0.78 
(7) 
Paradoxical response to 
sedation 
2.94 0.70 
(85) 
0.71 
(79) 
0.67 
(6) 
Demographic/Diagnostic 
Characteristics 
    
Trisomy 21  2.98 0.71 
(86) 
0.71 
(79) 
0.78 
(7) 
Previous sedation exposure 2.82 0.65 
(79) 
0.65 
(73) 
0.67 
(6) 
Not able to verbally 
communicate 
2.36 0.43 
(52) 
0.41 
(46) 
0.67 
(6) 
>90th percentile for BMI 1.96 0.24 
(29) 
0.23 
(26) 
0.33 
(3) 
Oncologic diagnosis 1.914 0.23 
(28)4 
0.23 
(26)2 
0.22 
(2) 
Moderate or severe cerebral 
disability 
2.05 0.22 
(27) 
0.22 
(25) 
0.22 
(2) 
Moderate or severe overall 
disability 
1.93 0.17 
(20) 
0.16 
(18) 
0.22 
(2) 
Bronchiolitis 1.554 0.09 
(11)4 
0.10 
(11)2 
0 
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PALISI, Pediatric Acute Lung Injury & Sepsis Investigators; SCCM, Society for 
Critical Care Medicine; SBS, State Behavioral Scale; BMI, Body mass index.  
Data presented as mean or I-CVI (n of respondents who ranked item as quite or 
highly relevant). 
1 Total n=119. 
2 Total n=111. 
3 Total n=8. 
4 Total n=120.   
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Table 3. Summary of Free-Text Responses 
          n 
“Other” demographics/diagnoses/characteristics that the difficult-to-sedate  
child typically has (n=17)         
Infant/toddler        5 
Lengthy PICU stay       1 
Prior history of delirium      1 
Airway repair        1 
Intoxicated        1 
Parents’ expectations       1 
>5 days of sedation       1 
Autism Spectrum Disorder      1 
ECMO/ECLS or CRRT      1 
ADHD, anxiety disorder, other psychiatric diagnosis  1 
Transplant recipient       1 
Multi-organ dysfunction      1 
Prematurity        1 
 
Other criteria that characterize the difficult-to-sedate child phenotype (n=61)  
Age ≤4 years        12  
Multiple drugs/bolus doses      8  
Diagnosis        5 
Psychiatric diagnosis (e.g., anxiety, autism, ADHD)  5  
Sleep/day-night cycling issues     5  
Anxious parents       4  
Rapid change in sedation level     4 
Nursing factors (e.g., experience, nurse/patient ratio)  3 
Patient instability limits sedation doses    3 
Activity limited by technology or instability    2 
Adolescent        2 
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History of negative sedation experience    2 
Other         6 
 
PICU, pediatric intensive care unit; ECMO, extracorporeal membrane 
oxygenation; ECLS, extracorporeal life support; CRRT, continuous renal 
replacement therapy; ADHD, attention-deficit/hyperactivity disorder. 
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Appendix A. Text of PALISI and SCCM Survey Participation Request Emails 
Dear PALISI Network Colleagues, 
We are interested in establishing face validity for criteria that will be used in a study 
identifying the "difficult to sedate child" phenotype, and would appreciate your expert 
opinion.  Please take a few minutes to answer 8 questions on our Qualtrics survey 
https://upenn.co1.qualtrics.com/XXXXXXXX 
Data are encrypted and results will be reported in aggregate. You will have an 
opportunity to add a comment at the end of the survey. Thank you for taking the time to 
review and respond. 
 
Dear SCCM Pediatric Sedation Study Group Colleagues, 
We are interested in establishing face validity for criteria that will be used in a study 
identifying the "difficult to sedate child" phenotype, and would appreciate your expert 
opinion.  Please take a few minutes to answer the following 8 questions. NOTE: If you 
have previously taken this survey, distributed to you as a PALISI member, thank you for 
your participation.  We request that you please answer question 1.  
To start the survey please clink on this link: https://upenn.co1.qualtrics.com/XXXX 
Please do not forward to your colleagues, as we would like to know your opinion as a 
member of the SCCM Task Force.  
Data are encrypted and results will be reported in aggregate. You will have an 
opportunity to add a comment at the end of the survey. Thank you for taking the time to 
review and respond. 
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Appendix B.  Difficult to Sedate Survey (SCCM Version) 
Have you completed this survey as a PALISI member? 
 1- Yes 
 2- No 
NOTE: If “Yes” was selected, the survey skipped all remaining questions and the text 
“Thank you for your previous participation” was displayed 
 
The "difficult to sedate child"... (assuming pain is adequately controlled and sedation 
medication doses are appropriate) 
 
1. Exhibits a State Behavioral Scale (SBS) score of +1 (restless and difficult to calm) or 
+2 (agitated) for two consecutive hours 
 1- Not Relevant 
 2- Somewhat Relevant 
 3- Quite Relevant 
 4- Highly Relevant 
 
2. Exhibits a consistent pattern of agitation, demonstrated by a daily modal (most 
frequently occurring) SBS score of +1 (restless and difficult to calm) or +2 (agitated) 
 1- Not Relevant 
 2- Somewhat Relevant 
 3- Quite Relevant 
 4- Highly Relevant 
 
3. Requires intermittent paralytic doses for sedation management 
 1- Not Relevant 
 2- Somewhat Relevant 
 3- Quite Relevant 
 4- Highly Relevant 
 
4. Requires sedation medication doses above the 90th percentile of usual starting 
doses (e.g. >0.2 mg/kg/hour for morphine or midazolam)   
 1- Not Relevant 
 2- Somewhat Relevant 
 3- Quite Relevant 
 4- Highly Relevant 
 
 
5.  Requires three or more sedative classes simultaneously to achieve target sedation 
 1- Not Relevant 
 2- Somewhat Relevant 
 3- Quite Relevant 
 4- Highly Relevant 
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6. Experiences sedation-related events that include the following: 
 
 1- Not Relevant 
2- 
Somewhat 
Relevant 
3- Quite 
Relevant 
4- Highly 
Relevant 
a) Unplanned 
endotracheal 
extubation 
b) Unplanned removal of 
any invasive device 
        
c) Reports of a 
paradoxical response 
to sedation 
        
d) Suspected of having 
delirium         
 
7. Typically has the following demographics/diagnoses/characteristics: 
 
 1- Not Relevant 
2- Somewhat 
Relevant 
3- Quite 
Relevant 
4- Highly 
Relevant 
a) >90th percentile for 
BMI         
b) History of previous 
sedative  exposure         
c) Bronchiolitis         
d) Oncologic diagnosis         
e) Trisomy 21         
f) Moderate or severe 
cerebral disability         
g) Moderate or severe 
overall disability         
h) NOT able to verbally 
communicate         
i) Other (please list):         
 
8. Please list any other criteria that you feel characterizes the "difficult to sedate child" 
phenotype. 
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9. Please select what best describes your role: 
 Attending Physician 
 Pediatric ICU Fellow 
 Advanced Practice Nurse 
 Nurse Scientist 
 Respiratory Therapist 
 Research Assistant 
 Pharmacist 
 Other (please list) ____________________ 
 
10. Please use the drop down menu to provide the name of your organization. If your 
organization is not listed please select "other" (last item in the drop down box). 
 
11. Please provide any closing thoughts that you think may be important to consider with 
regard to the "difficult to sedate child" phenotype. 
Thank you .... The END!!  Please click the Next (>>) button to submit your survey.  
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CHAPTER 4 
 
 
 
Characteristics of the Difficult-to-sedate Child Clinical Phenotype 
 
 
  
 
 
Target Journal: Pediatric Critical Care Medicine 
Key Words: child; classification and regression tree; critical care; latent class analysis; 
phenotypes; sedation; 
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Abstract  
Objective: To characterize the difficult-to-sedate child clinical phenotype in a cohort of 
children intubated and ventilated for acute respiratory failure. 
Design: Secondary analysis of prospectively collected data from the Randomized 
Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial. Latent 
Class Analysis was used to characterize the variability in sedation response through the 
first three days after endotracheal intubation to operationalize the difficult-to-sedate child 
clinical phenotype. Classification and Regression Tree methodology was used to 
develop branching algorithms that identified the characteristics of patients at high-risk for 
being difficult-to-sedate.  
Setting: Thirty-one PICUs in the U.S. 
Patients: 2,449 patients 2 weeks to 17 years old receiving mechanical ventilation for 
respiratory failure. 
Interventions: None.  
Measurements and Main Results: Latent Class Analysis identified a two-class model as 
the best fit, with need for adjunctive medications, less organ failure, occurrence of 
inadequate sedation events, and normal cognitive state identified as being indicative of 
the difficult-to-sedate child latent class. Classification and Regression Tree analysis 
produced a tree with 9 nodes.  The best fitting model classified 18% of children as likely 
to be difficult-to-sedate. The most important sorting variable was need for adjunctive 
medications.   
Conclusions: Latent Class and Classification and Regression Tree analysis were useful 
techniques in identifying likely phenotypic characteristics and clinical risk factors of the 
difficult-to-sedate child clinical phenotype.  Further prospective study, with the inclusion 
of genetic markers, will be useful in validating these findings. 
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Patients admitted to the Pediatric Intensive Care Unit (PICU) are a 
heterogeneous group on many factors including age, diagnosis, severity of illness, and 
medical history.  One of the most common therapies children admitted to the PICU 
receive is mechanical ventilation.  To help them tolerate this invasive therapy, the 
majority of children receive sedation, primarily benzodiazepines, but there is great 
variability in practice and many classes of sedation medication are routinely used.(1,2,3).  
Response to sedation is also heterogeneous.  The majority of children respond as 
anticipated to appropriately dosed sedation, and are considered to be adequately 
sedated.   
However, there are children who do not respond as expected.  Some children are 
over sedated and require less drug than expected.  A more challenging group are those 
children who are persistently agitated, requiring higher than anticipated doses and 
sedation medications from multiple classes.(4)  These children may be referred to as 
refractory to sedation, sedation failures, or difficult-to-sedate, and are at risk for adverse 
events such as unplanned endotracheal tube extubation or removal of other critical 
devices such as central venous catheters.(5)   
In addition to sedation-related adverse events, the requirement for higher doses 
and multiple classes of sedative agents may cause hypotension, bradycardia, drug-
specific iatrogeneses such as iatrogenic withdrawal syndrome.(6,7)  Also concerning is 
recent data that suggests many of most commonly used sedation medications may 
negatively impact a young child’s neurocognitive development.(8) Midazolam, 
lorazepam, pentobarbital, ketamine and propofol labeling now carry an FDA required 
Black Box warning indicating that brain development in children three and under may be 
affected by exposure to these drugs.(9)  
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Aside from noting that this group of difficult-to-sedate children exists within the 
heterogeneous PICU population, there is very limited data describing them. Clinical 
phenotypes have been useful in characterizing patients identified as having a 
heterogeneous disease process into groups with similar characteristics. This approach 
has stimulated research aimed at identifying effective phenotype specific treatment 
strategies and has been a successful strategy for patient populations with asthma, 
sepsis, and Acute Respiratory Distress Syndrome.(10-12)  Two statistical modeling 
approaches are frequently used to describe clinical phenotypes.  Latent class analysis 
(LCA) characterizes subgroups within a particular patient population based on clinical 
and biological data.  Classification and regression tree analysis (CART) has been used 
as a way to predict a particular outcome for a subgroup of patients. The purpose of this 
study was to characterize the difficult-to-sedate clinical phenotype in a cohort of children 
intubated and ventilated for acute respiratory failure using these two machine learning 
techniques.   
Materials and Methods 
This is a secondary analysis of data from the RESTORE (Randomized 
Evaluation of Sedation Titration fOr Respiratory failure; U01 HL086622) study.(18)  
RESTORE was a cluster randomized clinical trial designed to test a nurse-implemented 
goal-directed approach to sedation management in pediatric patients supported on 
mechanical ventilation.  The study captured a large amount of prospectively collected 
and validated sedation data in a cohort of 2,449 children from 31 participating pediatric 
intensive care units. Data collection occurred between June 2009 and December 2013. 
Inclusion and exclusion criteria as well as specifics of the protocol are detailed in the 
study report.(18) The institutional review board of each participating center approved the 
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RESTORE trial. Parental permission was obtained for each enrolled child. When 
feasible, assent was also obtained from children 8 years and older. 
For this secondary analysis, we examined data from the first three days of study 
enrollment only. We chose these days because it is likely the subset of patients that 
represent the difficult-to-sedate child clinical phenotype demonstrate this characteristic 
early in their treatment course. We also sought to avoid possible confounding effects 
related to sedation tolerance or iatrogenic withdrawal syndrome (IWS). We examined 
demographic, physiological, developmental and clinical characteristics, as well as 
patterns of opioid, benzodiazepine, and other sedative medication administration with 
the goal of identifying the characteristics of the difficult-to-sedate child clinical 
phenotype. We included all RESTORE subjects who contributed at least two days of 
data. There were no exclusion criteria aside from those of the parent study.  
We identified an initial list of variables for inclusion in the LCA and CART models 
based on a review of the literature and concept analysis.(20)  We then surveyed 
pediatric critical care clinicians to establish face and content validity of these variables 
and to identify other variables to consider for inclusion in the model.(21) Based on the 
results of our survey, additional unpublished variables were added to our initial list. The 
complete list of variables used in the models is available as Supplement Table 1 but 
included baseline demographics, sedation characteristics such as classes of sedation 
agents received on study day 0-3, as well as the incidence of sedation related events on 
study day 0-3 such as unplanned device removal. The majority of the variables included 
in the models were ordinal or categorical, but continuous variables are appropriate for 
use in CART analysis, so age, weight, body mass index (BMI), blood urea nitrogen 
(BUN), or alanine amino transferase (ALT) were included as continuous variables in the 
CART analysis. 
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We used an exploratory LCA to analyze the RESTORE data, with the goal of 
characterizing the difficult-to-sedate child clinical phenotype. Forty demographic and 
clinical variables were included in the initial analysis as possible class defining variables 
in the LCA model.  For this analysis, we converted all but one variable into a binary 
categorical variable. We created a dummy variable for each diagnosis group, resulting in 
six diagnoses variables. The Pediatric Risk of Mortality version III (PRISM III-12) score 
was converted to a standardized z-score with a mean of 0 and a standard deviation of 1. 
The complete data set was randomly divided into a training (n= 1,470) and validation set 
(n= 979), with 60% of cases assigned to the training set and 40% to the validation set. 
The CART training and validation sets were compared using the t test or chi-squared 
test, as appropriate (see Table 1) using IBM SPSS Statistics 24 (IBM, Armonk, NY, 
USA).  As is appropriate in LCA, clinical outcomes were not included in identifying the 
number of latent classes. We used mixture modeling to test a series of 2, 3, 4 and 5 
class latent class models using the discovery data set.  We used recommended criteria 
for model evaluation and selection, including the sample-size adjusted Bayesian 
information criterion (ABIC), Aikake information criterion (AIC), the Vuong-Lo-Mendell-
Rubin Likelihood Ratio Test (VLMRLRT), and the degree of entropy, used to assess 
classification quality.(23, 24) We assessed the parametric Bootstrapped Likelihood Ratio 
Test, but it remained low for all models, so is not included here. MPlus, version 7.4 
(Muthén & Muthén, UCLA) was used for the LCA.(13,14)  MPlus uses full-information 
maximum likelihood in latent class model estimation, which allows use of all subjects, 
including those with missing data.(25) Each model fitted was evaluated using the criteria 
listed above, and the best fitting model which established the number of latent classes 
was selected.  We then repeated these analyses with the validation data set, to evaluate 
model stability across the two groups.   
 
 
129 
  
 
We used CART analysis to classify patients into risk categories for being difficult-
to-sedate. Unlike LCA, CART requires an outcome variable. Using the operational 
definition of difficult-to-sedate child clinical phenotype developed from our review of the 
literature and survey of expert PICU clinicians, we created a composite difficult-to-sedate 
categorical outcome variable, which was positive if the subject had a State Behavioral 
Scale (SBS) score of +1/+2 (agitated) and was receiving at least two times the usual 
starting dose of an opioid or benzodiazepine continuous infusion on any study day from 
day 0-3. CART uses a branching algorithm to classify patients into groups, starting with 
2 groups at the first decision node, using a chi-square statistic for each possible 
predictor variable.  The algorithm then assigns the predictor variable with the highest 
calculated logworth statistic as the candidate for splitting the group into two additional 
nodes.(26)  We used the entire RESTORE dataset to build the classification tree using 
the rpart package in RStudio (Foundation For Open Access Statistics, Boston, MA). We 
used an unsupervised approach to model development. Cross validation was used to 
identify the most accurate and predictive tree.  We used the process of pruning to 
remove nodes with few observations by setting a complexity parameter, in order to 
minimize the cross-validation error rate and identify a workable model. Finally, we ran 
the same model by control or intervention group to assess stability of the tree.   
Results 
Table 1 compares the cohort of difficult-to-sedate subjects, identified as positive 
for the outcome variable (n= 473) to those identified as not difficult-to-sedate (n= 1503) 
using the t test or chi-squared test, as appropriate.  There were significant differences 
between the usual care and protocol groups in the parent study on several variables.  
Children classified as difficult-to-sedate had a younger age, were less likely to have a 
primary diagnosis of asthma, were more likely to be premature or have previous 
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exposure to opioids or benzodiazepines and were more likely to have received fentanyl 
as their primary opioid.  In addition, the difficult-to-sedate children were less likely to 
have elevated blood urea nitrogen or alanine aminotransferase levels. 
Latent Class Analysis 
The training and validation cohorts for the LCA were randomly generated, and 
the only statistically significant difference between the groups was that patients in the 
training group were more likely to have an elevated ALT. A 2-class model was identified 
as the best fit in both the training and validation cohorts, based on both fit statistics and 
interpretability of the model. Although the AIC and ABIC continued to decrease in the 3 
class model, the VLMRLRT demonstrated a non-significant p-value of 0.76 in the 
training and 0.78 in the validation cohort, indicating the smaller, 2 class model was a 
better fit. The best log likelihood was replicated in >25% of 1000 iterations.  Table 2 lists 
the fit statistics for the various models estimated in the LCA.  
The children who make up the difficult-to-sedate phenotype identified here have 
less overall organ failure.  They are less likely to require vasoactive medications, do not 
have hepatic or renal failure, have normal ratings for Pediatric Outcome Performance 
Category (POPC) and Pediatric Cerebral Performance Category (PCPC), and are not 
likely to have an abnormal level of consciousness.  This group is more likely to require 
neuromuscular blockade to manage agitation, occurrences of an inadequate sedation 
management event (SBS +1 or +2 for 2 consecutive hours, not associated with an 
extubation attempt), and having a daily SBS high score of +1/+2.  Figure one provides a 
comparison of the difficult-to-sedate and not difficult-to-sedate groups by phenotype 
characteristic.  Of note, the probability of class membership differed between the training 
and validation groups, with the training cohort having a 43% probability of belonging to 
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the difficult-to-sedate class, and the validation cohort having a 19% chance of belonging 
to the difficult-to-sedate class. 
CART Analysis 
 The group classified as difficult-to-sedate for the CART analysis were younger, 
more likely to receive fentanyl as the primary opioid, received more classes of sedation 
medications, be admitted with a diagnosis of pneumonia, and have a history of 
prematurity and previous exposure to sedation medications.  Patients classified as not 
difficult-to-sedate were more likely to be admitted with a diagnosis of asthma or acute 
respiratory failure related to sepsis. The final pruned decision tree produced by the 
CART analysis of all subjects had nine splitting nodes, with the primary node predicated 
on whether or not the child received any adjunctive sedation medications, and is 
displayed in Figure 2.  Other important splitting nodes were daily modal SBS score, 
occurrence of an inadequate sedation management event, presence of an elevated 
blood urea nitrogen level, age, weight, and race.  Supplement Figure 1 presents variable 
importance for the top ten variables.   
 The prevalence of the difficult-to-sedate child phenotype in this sample was 
18.6% (386/2078 subjects), based on the outcome variable developed for the CART 
analysis.  Due primarily to missing data related to SBS scores, only 821 subjects were 
included in the CART analyses.  Accuracy to correctly predict a child who was difficult to 
sedate was 0.83 (CI, 0.798- 0.851). The sensitivity for the model was low at 21%, with a 
high level of false positives and false negatives. The decision tree was highly specific, 
correctly identifying 97% of difficult-to-sedate child cases. Table 3 reports the test 
characteristics of the CART analysis. 
Discussion  
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 The difficult-to-sedate child in our sample had less organ failure, less 
cognitive impairment, higher modal SBS scores and required more than two 
agents to manage agitation, including in some situations neuromuscular 
blockade. This study was exploratory and identified the clinical characteristics of the 
difficult-to-sedate child phenotype proposed in our operational definition and conceptual 
model.  We used two different machine-learning methodologies in this analysis, to 
evaluate if any characteristics were supported in both types of models. Regardless of the 
methodology used, sorting points included the requirement for adjunctive 
medications, presence of organ failure, particularly renal failure, occurrences of 
inadequate sedation events, high daily modal SBS scores and need for vasoactive 
medications.   
There were some differences noted when comparing the results of each analysis. 
The LCA is a descriptive model, which assigns each subject to a single class and for 
each indicator variable included in the model provides the probability that any member of 
the class will demonstrate that variable. LCA is atheoretical; it does not assess the data 
based on an outcome, but rather looks for and reports patterns in the data.  The results 
of this LCA also provide a more descriptive picture of a child who is not difficult-to-
sedate being likely to have renal or hepatic failure, an altered level of consciousness, a 
history of alterations in cerebral and overall performance, and a requirement for 
vasoactive medications.  The finding that children with organ failure were more likely to 
be in this class is supported by a study which found that midazolam clearance was 
decreased in critically ill children.(28) In order to assess the strength of our findings, we 
randomly divided our data set, and the findings were very similar across the two groups, 
supporting the characteristics identified here for the difficult-to-sedate child clinical 
phenotype. 
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The CART analysis predicts the likelihood of an outcome, so takes a different 
approach to data analysis.  The data is also analyzed for patterns, but at each node or 
sorting point, there are only two options for assignment.  However, many different paths 
may lead to the outcome of interest. The tree shown in Figure 2 has three terminal 
nodes positive for the difficult-to-sedate outcome and the difficult-to-sedate outcome was 
reached through three paths along the decision tree.  Important variables in the CART 
analysis included primary diagnosis; age, with young age being more predictive of the 
outcome; weight, with weight > 8 and < 22 kg being predictive of the outcome; and 
requirement for adjunctive sedation medication as an important predictor.  The weight 
range reported here is typical of the toddler and pre-school age range, which was one of 
the characteristics identified in our survey of PICU experts.  It is also a finding supported 
in the literature.  For example, de Gast Bakker et al. identified that in a population of 
mechanically ventilated children, children 1-4 years of age required a significantly higher 
dose of midazolam, starting on their first day of intubation, and other studies have 
identified that age impacts both the pharmacokinetics and pharmacodynamics of 
medications.(29-31) 
  This is one of the first studies to attempt to determine the incidence of this clinical 
phenotype.  Approximately 18% of subjects in the CART analysis demonstrated the 
difficult-to-sedate outcome.  Although this was one point on which the training and 
validation data sets differed in the LCA, occurrence of the difficult-to-sedate child 
phenotype was at a minimum 19%.  This finding demonstrates that this clinical 
phenotype is not rare.  Combining the finding of the CART analysis that these children 
tend to be young, and the concern that sedation medications may negatively impact 
cognitive development, exploration of this clinical phenotype warrants further 
investigation.  Both the LCA and the CART analysis demonstrated these children require 
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more classes of medication, and still are less likely to reach their target sedation goal as 
demonstrated by the higher modal SBS scores for this group and the more frequent 
incidence of inadequate sedation management events.   
There are limitations to consider in this study.  Although we used a rigorous 
process to identify variables to include in the model, it is possible that we omitted an 
important variable.  The outcome variable used in the CART analysis was a composite 
of two sedation related variables. It is possible that a different outcome variable would be 
more appropriate.  Secondary analyses of existing data sets presents some limitations. 
Data collected may not include variables important to the question being investigated. 
However, our question of interest generally fit the data available from the parent study. 
 The parent study was a cluster-randomized trial, with sites being randomized to 
the intervention or control arms, so significant differences in sedation practices between 
the control sites would impact study results. We carefully evaluated our data considering 
treatment arm assignment and did find some significant differences, which could have 
affected our findings. Young age, primary diagnosis, and primary opioid received were 
important predictor variables in the CART analysis and there were significant differences 
seen between the usual care and protocol groups in the parent study on these variables. 
Subsequent prospective studies could address this limitation.   
Sedation scores and medication data are key variables of interest in this study. 
Low interrater reliability in sedation scoring would bias our results, particularly for the 
CART analysis, as our outcome variable was a composite variable, which included a 
sedation score. The parent trial assessed interrater reliability routinely throughout the 
study, and demonstrated strong agreement with no difference in Fleiss’s kappa for the 
SBS based on unit size or timing of assessment (earlier or later in the study).(32)  The 
parent study population included only children with acute respiratory failure, a subset of 
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the PICU population, which limits generalizability of our findings.  Missing data, which 
may decrease power, was a concern, as approximately 9% of SBS scores were missing 
for the study days in question and in the control group. This was particularly true in the 
CART analysis, as SBS scores were part of the composite outcome variable.  In 
addition, other missing data points also decreased the final sample size.  
Finally, other clinical entities, particularly tolerance, iatrogenic withdrawal 
syndrome and delirium share some of the characteristics seen in the difficult-to-sedate 
child.  We felt that by examining data from days early in the clinical course, we would 
avoid overlap with these potent confounders.  We found that children were identified as 
being positive for the difficult-to-sedate outcome variable beginning on their first day of 
intubation and on average this group met the difficult to sedate criteria on two of the 
days studied.  
This study included primarily clinically observable characteristics in describing 
this clinical phenotype, such as medication classes and doses received, sedation 
scores, episodes of agitation, and level of consciousness.  BUN and ALT were included 
in the model, but no other biomarkers or genetic samples were included.  This clinical 
phenotype has not been previously described and the goal of this study was to 
characterize the phenotype.  However, it is likely that there is a genetic basis underlying 
the clinical phenotype of the difficult-to-sedate child.  There is emerging evidence that 
polymorphisms in the cytochrome p450 enzymes may influence the metabolism of 
benzodiazepines(33), and identifying a population at risk would facilitate investigation of 
the genetic basis of this phenotype.  The utility of characterizing this phenotype is that it 
identifies a group of patients to target in a genome-wide association study.  
Understanding the underlying genetic basis of the difficult-to-sedate clinical phenotype 
would support early and appropriate medication selection and dosing. 
 
 
136 
  
 
CONCLUSIONS 
 This study tested a model characterizing the difficult-to-sedate child and 
identified that these children are typically young, require more adjunctive medications, 
are more likely to have inadequate sedation management events, have high daily modal 
SBS scores despite receiving high doses of opioids and benzodiazepines, have less 
organ failure, particularly renal failure, and less need for vasoactive medications. In this 
cohort of critically ill children, the incidence of this clinical phenotype was approximately 
18%, indicating that this phenotype deserves further investigation. The next step would 
be to test and refine this model using prospectively collected data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
137 
  
 
References  
1. Baarslag MA, Allegaert K, Knibbe CAJ, van Dijk, M, Tibboel D. (2017), 
Pharmacological sedation management in the paediatric intensive care unit. J Pharm 
Pharmacol, 69: 498–513. doi:10.1111/jphp.12630 
2. Guerra GG, Joffe AR, Cave D, Duff J, Duncan S, Sheppard C, et al. Survey of 
sedation and analgesia practice among Canadian pediatric critical care physicians. 
Pediatr Crit Care Med. 2016;17(9):823-30. doi: 10.1097/PCC.0000000000000864 
3. Kudchadkar SR, Yaster M, Punjabi NM. Sedation, sleep promotion, and delirium 
screening practices in the care of mechanically ventilated children: a wake-up call for 
the pediatric critical care community*. Crit Care Med. 2014 Jul;42(7):1592-600. doi: 
10.1097/CCM.0000000000000326 
4. Vet NJ, Ista E, de Wildt SN, van Dijk M, Tibboel D, de Hoog M. Optimal sedation in 
pediatric intensive care patients: a systematic review. Intensive Care Med. 
2013;39(9):1524-34. 
5. Grant MJ, Scoppettuolo LA, Wypij D, Curley MA, RESTORE Investigative Team. 
Prospective evaluation of sedation-related adverse events in pediatric patients 
ventilated for acute respiratory failure. Crit Care Med. 2012 Apr;40(4):1317-23. 
6. Davidson A, Flick RP. Neurodevelopmental implications of the use of sedation and 
analgesia in neonates. Clin Perinatol. 2013 Sep;40(3):559-73. 
7. Rappaport BA, Suresh S, Hertz S, Evers AS, Orser BA. Anesthetic neurotoxicity--
clinical implications of animal models. N Engl J Med. 2015;372:796-7. doi: 
10.1056/NEJMp1414786 
8. Johnson PN, Miller JL, Hagemann TM. Sedation and analgesia in critically ill 
children. Adv Crit Care. 2012;23(4):415-34. doi: 10.1097/NCI.0b013e31826b4dea 
 
 
138 
  
 
9. US Food and Drug Administration. FDA review results in new warnings about using 
general anesthetics and sedation drugs in young children and pregnant women. 
4/28/17.  https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm. Accessed 5/13/17 
10. Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA, et al. 
Classification of childhood asthma phenotypes and long-term clinical responses to 
inhaled anti-inflammatory medications. Journal of Allergy & Clinical Immunology. 
2014;133(5):1289-300. 
11. Wong, H. R., Cvijanovich, N. Z., Anas, N., Allen, G. L., Thomas, N. J., Bigham, M. T., 
... Lindsell, C. J. (2016). Pediatric Sepsis Biomarker Risk Model-II: Redefining the 
Pediatric Sepsis Biomarker Risk Model with Septic Shock Phenotype. Critical Care 
Medicine, 44(11), 2010-2017. doi: 10.1097/CCM.0000000000001852 
12. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. 
Subphenotypes in acute respiratory distress syndrome: latent class analysis of data 
from two randomised controlled trials. The Lancet Respiratory Medicine. 
2014;2(8):611-20. 
13. Lanza ST, Tan X, Bray BC. Latent class analysis with distal outcomes: A flexible 
model-based approach. Structural Equation Modeling A Multidisciplinary Journal. 
2013;20(1):1-26 doi: 10.1080/10705511.2013.742377 
14. Vermunt, J. K., & Magidson, J. (2002). Latent class cluster analysis. In J. Hagenaars, 
& A. McCutcheon (Eds.), Applied latent class analysis (pp. 89-106). Cambridge: 
Cambridge University Press. 
15. De'ath G, Fabricius K. Classification and Regression Trees. Ecology 2000 81;3178-
92. 
 
 
139 
  
 
16. Kuhn, L., Page, K., Ward, J., & Worrall-Carter, L. (2014). The process and utility of 
classification and regression tree methodology in nursing research. Journal of 
Advanced Nursing, 70(6):1276-86. doi: 10.1111/jan.12288.. 1276-1285 
17. Lewis R. An introduction to classification and regression tree (CART) analysis. 
Available at:http://www.saem.org/download/lewis1.pdf. Accessed April 1, 2015. 
18. Curley MA, Wypij D, Watson RS, Grant MJ, Asaro LA, Cheifetz IM, et al. 
Protocolized sedation vs usual care in pediatric patients mechanically ventilated for 
acute respiratory failure: a randomized clinical trial. JAMA. 2015 Jan 27;313(4):379-
89. 
19. Curley MA, Harris SK, Fraser KA, Johnson RA, Arnold JH. State Behavioral Scale: a 
sedation assessment instrument for infants and young children supported on 
mechanical ventilation. Pediatric Critical Care Medicine. 2006 Mar;7(2):107-14. 
20. Lebet R, Curley MAQ. The Difficult-to-Sedate Child: A Concept Analysis.  2017. 
Manuscript in development. 
21. Lebet R, Asaro LA, Zuppa AF, Curley MAQ. Face and Content Validity of Variables 
Associated with the Difficult-to-Sedate Child in the Pediatric Intensive Care Unit: A 
Survey of Pediatric Critical Care Clinicians. 2017. Manuscript in review. 
22. Polit DF, Beck CT, Owen SV. Is the CVI an Acceptable Indicator of Content Validity? 
Appraisal and Recommendations. Res Nurs Health. 2007 August;30(4):459-67 
23. Nylund KL, Asparouhov T,  Muthén, BO. Deciding on the number of classes in latent 
class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct 
Equ Modeling. 2007;14(4):535-569 
24. Tein J, Coxe S, Cham H5b. Statistical power to detect the correct number of classes 
in latent profile analysis. Struct Equ Modeling. 2013; 20(4): 640–657. 
doi:10.1080/10705511.2013.824781. 
 
 
140 
  
 
25. Muthén LK, Muthén  BO. MPlus User’s Guide. Available at: 
https://www.statmodel.com/download/usersguide/Mplus%20Users%20Guide%20v6.
pdf.  Accessed 5/15/2017. 
26. Ebell MH, Afonso AM, Geocadin RG; American Heart Association’s Get With the 
Guidelines-Resuscitation (formerly National Registry of Cardiopulmonary 
Resuscitation) Investigators. Prediction of survival to discharge following 
cardiopulmonary resuscitation using classification and regression trees. Crit Care 
Med. 2013 Dec;41(12):2688-97. doi: 10.1097/CCM.0b013e31829a708c. 
27. Lanza ST, Collins LM, Lemmon DR, Schafer JL. PROC lca: A SAS procedure for 
latent class analysis. Struct Equ Modeling. 2007 14(4):671–694. 
28. Ince I, de Wildt SN, Peeters MY, Murry DJ, Tibboel D, Danhof M, et al. Critical illness 
is a major determinant of midazolam clearance in children aged 1 month to 17 years. 
Ther Drug Monit. 2012 Aug;34(4):381-9. 
29. de Gast-Bakker DA, van der Werff SD, Sibarani-Ponsen R, Swart EL, Plotz FB. Age 
is of influence on midazolam requirements in a paediatric intensive care unit. Acta 
Paediatrica. 2007 Mar;96(3):414-7. 
30. Admiraal R, van Kesteren C, Boelens JJ, Bredius RG, Tibboel D, Knibbe CA. 
Towards evidence-based dosing regimens in children on the basis of population 
pharmacokinetic pharmacodynamic modelling. Arch Dis Child. 2014 Mar;99(3):267-
72. 
31. Zuppa AF, Barrett JS. Pharmacokinetics and pharmacodynamics in the critically ill 
child. Pediatr Clin North Am. 2008 xii; Jun;55(3):735-55. 
32. Lebet R, Hayakawa J, Chamblee TB, Tala JA, Singh N, Wypij D, Curley MAQ. 
Maintaining interrater agreement of core assessment instruments in a multicenter 
controlled randomized clinical trial. Nurs Res. 2017 
 
 
141 
  
 
33. Fukasawa T, Suzuki A, Otani K. Effects of genetic polymorphism of cytochrome 
P450 enzymes on the pharmacokinetics of benzodiazepines. Journal of Clinical 
Pharmacy & Therapeutics. 2007 Aug;32(4):333-41. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
142 
  
 
Table 1: Demographic and Patient Characteristics of Sample by Outcome First Three 
Days of Therapy for the LCA & CART 
 LCA 
 
n = 2449  
CART 
(N=2224) 
 
DTS Not DTS P value 
  473 (21) 1976 (79)  
Intervention group, No. (%)  240 (51) 985 (50) 0.72 
Age at PICU admission, median 
(IQR), years 
1.9 (0.4-8) 1.6 (0.6-
4.5) 
2.0 (0.3-
9.3) 
<.001 
Female, No., (%) 666 (46) 221 (47) 880 (45) 0.294 
Non-Hispanic white, No., (%) 725 (51) 227 (48) 1006 (51) 0.25 
Baseline PCPC = 1, No., (%) 1094 (76) 362 (77) 1503 (76) 0.049 
Baseline POPC = 1, No., (%) 1024 (71) 329 (70) 1418 (72) 0.235 
PRISM III-12 score, median (IQR) 8 (3-13) 7 (2-12) 7 (3-13) 0.645 
Primary diagnosis, No., (%) 
     Pneumonia 
     Bronchiolitis 
     Acute respiratory failure related 
 to sepsis 
     Asthma or reactive airway 
 disease 
     Aspiration pneumonia 
     Other 
 
493 (34) 
424 (30) 
200 (14) 
 
121 (8) 
 
75 (5) 
122 (9) 
 
179 (38) 
110 (23) 
49 (10) 
 
59 (13) 
 
25 (5) 
51 (11) 
 
647 (33) 
547 (28) 
308 (16) 
 
148 (8) 
 
124 (6) 
202 (10) 
 
0.03 
0.05 
0.003 
 
<0.001 
 
0.417 
0.718 
Past medical history, No., (%) 
     Prematurity 
     Previous exposure to 
 opioids/benzodiazepines 
     Oncology diagnosis 
     Chromosomal abnormality 
 
206 (14) 
221 (15) 
100 (7) 
58 (4) 
 
89 (18) 
94 (20) 
 
30 (6) 
22 (5) 
 
280 (14) 
300 (15) 
 
161 (8) 
86 (4) 
 
0.032 
<0.001 
 
0.113 
Weight for age > 95th percentile, No., 
 (%) 
324 (13) 61 (13) 263 (14) 0.164 
Pt characteristics  PICU Days 0-3 
Primary opioid agent, No., (%) 
     Morphine 
     Fentanyl 
 
487 (34) 
918 (64) 
 
105 (22) 
362 (77) 
 
728 (37) 
1204 (69) 
 
<0.001 
At least one modal SBS score 
 +1/+2, No., (%) 
218 (15) 166 (36) 221 (11) 0.243 
Opioid dose ≥0.2 mg/kg/hour 
 morphine equivalents any 
 day, No., (%) 
343 (24) 358 (76) 240 (12) <0.001 
Benzodiazepine dose ≥0.2 
 mg/kg/hour midazolam 
 equivalents any day, No., (%)  
274 (17) 296 (63) 194 (10) <0.001 
Highest number of secondary 
 sedative agents received any 
 day, median (IQR) 
0 (0) 1 (0-2) 0 (0-1) <0.001 
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Unplanned removal of any device, 
 No. of  events, (%) 
38 (3) 15 (3) 42 (2) 0.255 
Inadequate sedation management 
 event 
141 (10) 166 (35) 122 (6) <0.001 
Received neuromuscular blockade 
 for agitation, No., (%) 
247 (17) 128 (27) 320 (16) <0.001 
BUN > 20, No., (%) 233 (16) 55 (12) 328 (17) 0.026 
ALT > 55, No., (%) 356 (25) 69 (15) 440 (22) 0.001 
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Table 2: Fit Statistics for Latent Class Models For 2 to 4 Class Models By Group 
 AIC ABIC Entropy VLMR LRT 
for k vs k-1 
classes 
(p-value) 
Percent of cohort per class 
     1 2 3 4 
Training Cohort         
2 Classes 56799.9 57007.9 0.84 -29520.9 
(<0.001) 
57 43   
3 Classes 54865.0 55177.1 0.91 -28302.0 
(0.76) 
17 42 41  
4 Classes 57007.9 55177.1 0.88 -27285.5 
(0.78) 
29 22 33 16 
Validation Cohort          
2 Classes 37066.8 37233.4 .99 -19257.5 
(<.001) 
19 81   
3 Classes 35966.6 36216.5 0.91 -18435.4 
(0.78) 
19 36 45  
4 Classes 53894.6 35716.6 0.88 -17836.3 
(0.78) 
28 24 18 30 
AIC= Akaike Information Criteria; ABIC= Sample-size Adjusted Bayesian Information Criteria;  
VLMR LRT= Vuong-Lo-Mendell-Rubin Likelihood Ratio Test; Parametric BLRT= Parametric Bootstrapped Likelihood Ratio Test. 
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Table 3: Test Characteristics of the Decision Tree 
Characteristic  
Number of subjects included 2078 
Subjects positive for DTS 386 
Number of true positives 32 
Number of true negatives 646 
Number of false positives 23 
Number of false negatives 120 
Accuracy (%, CI) 82.6 (0.799, 0.851) 
Sensitivity 0.211 
Specificity 0.966 
Positive predictive value 0.582 
Negative predictive value 0.843 
Positive likelihood ratio 6.21 
Negative likelihood ratio 0.82 
Prevalence 0.067 
CI= confidence interval; DTS= difficult-to-sedate
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Figures 
Figure 1: Comparison of Latent Class and Classification and Regression Tree 
Methodologies 
Latent Class Analysis is a hypothesis-free statistical technique that uses mixture 
modeling, and has been used extensively in clinical phenotype development studies to 
identify unobserved (latent) classes by building typologies or clusters based on 
observable variables within a data set.  In comparison to other statistical analyses, no 
outcome variable is included in the analysis.  The algorithm seeks previously 
unobserved patterns in the data by looking for patterns between the variables included 
in the analysis, and produces groups of patients that are as different as possible from 
each other. LCA works best with categorical or ordinal data.  (13,14)  
 
CART methodology is an exploratory data mining technique that searches large data 
sets looking for meaningful patterns.  It classifies populations into clinically meaningful 
risk categories, and is useful in uncovering complex interactions when many potential 
predictor variables and patterns of relationship exist. CART can use categorical, 
ordinal and continuous data. Unlike LCA, CART does require an outcome or response 
variable, which can be categorical or continuous.  CART produces cut points and 
ordering of decision nodes that clearly discriminate between groups with high and low 
risk for the response variable. The CART output includes a diagram of the tree 
produced by the analysis, which looks very similar to many algorithms used in clinical 
care. (15-17)   
 
LCA and CART are both non-parametric tests that do not require normally distributed 
data.  Both LCA and CART test statistical models, so multiple variations of the 
proposed model are analyzed.  The final best fitting model is selected based on model 
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fit statistics and interpretability of the model.  The model must then be validated by 
testing the model in other groups to see if it is reproduced.(13-17)   
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Figure 2: Latent Class Analysis Findings: Probability of Characteristics by Phenotype Assignment 
 
BUN= blood urea nitrogen in mg/dL; ISM= inadequate sedation management event; LOC= level of consciousness; PCPC= Pediatric 
Cerebral Performance Category; POPC= Pediatric Overall Performance Category 
0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80
Abnormal PCPC
Abnormal POPC
Abnormal LOC
History of asthma
Require vasoactive medications
BUN >20
Hepatic failure
Require adjunctive medications
High SBS score any day
ISM any day
Neuromuscular blockade for agitation
Probability of Characteristics by Phenotype Assignment
DTS Not DTS
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Figure 3: Classification and Regression Tree Decision Tree for Difficult-to-Sedate Child Clinical Phenotype 
 
BUN= blood urea nitrogen; DTS= difficult-to-sedate; ISM= inadequate sedation management event; # 3rd agents= number of   
classes of adjunctive medications received; SBS= State Behavioral Scale Score. 
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Supplement 1 
Table 1: Variables included in the Difficult-to-Sedate Analysis Linked to Survey of Expert 
PICU Clinicians 
Sedation Characteristics  LCA Variable CART Variable 
Requires 3 or more sedation 
classes simultaneously 
Received 3rd class of 
sedation medication 
Number of classes of 
additional sedation 
medication received 
Daily modal SBS +1/+2  Modal SBS score +1/+2 
any day 0-3 
Modal SBS score +1/+2 
any day 0-3 
SBS +1/+2 for 2 consecutive 
hours 
Inadequate sedation 
management event 
Inadequate sedation 
management event 
Doses >90th percentile of usual 
starting dose 
Morphine or midazolam 
equivalents ≥0.2 
mg/kg/hour 
Element in composite 
outcome variable 
Intermittent paralytic doses for 
sedation 
Received neuromuscular 
blockade for agitation 
Received 
neuromuscular 
blockade for agitation 
Sedation-related Events 
Suspected delirium  Number of events too 
small to include in 
analysis 
Number of events too 
small to include in 
analysis 
Unplanned endotracheal 
extubation 
Unplanned device 
Removal 
Unplanned 
endotracheal tube 
removal 
 
 
151 
  
 
Unplanned removal of an 
invasive device 
Unplanned device 
removal 
Unplanned device 
removal 
Paradoxical response to 
sedation 
Number of events too 
small to include in 
analysis 
Number of events too 
small to include in 
analysis 
Demographic/Diagnostic Characteristics 
Trisomy 21  PRISM III-12 
chromosomal 
abnormality 
PRISM III-12 
chromosomal 
abnormality 
Previous sedation exposure Past medical history of 
previous exposure 
Past medical history of 
previous exposure 
Not able to verbally 
communicate 
PCPC 
GCS 
LOC 
PCPC 
GCS 
LOC 
>90th percentile for BMI Overweight for age 
Normal BMI 
BMI 
Weight for Age 
Oncologic diagnosis PRISM III-12 cancer 
diagnosis 
PRISM III-12 cancer 
diagnosis 
Moderate or severe cerebral 
disability 
PCPC PCPC 
Moderate or severe overall 
disability 
POPC POPC 
Bronchiolitis Admission Diagnosis Admission Diagnosis 
Additional Variables Suggested by Experts 
Prematurity History of prematurity History of prematurity 
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Infant or toddler Age category Age 
Patient instability PRISM III-12 Z-score 
Vasoactive medications 
Cardiovascular, hepatic, 
renal, neurologic failure 
Elevated BUN or ALT 
PRISM III-12 Z-score 
Vasoactive medications 
Cardiovascular, hepatic, 
renal, neurologic failure 
Elevated BUN or ALT 
Diagnosis specific Admission diagnosis 
Asthma diagnosis 
Seizure disorder 
Admission diagnosis 
Asthma diagnosis 
Seizure disorder 
Additional factors suggested in the literature 
Gender Gender Gender 
Race/ethnicity Race, ethnicity Race, ethnicity 
Primary opioid (morphine vs. 
fentanyl) 
Primary opioid days 0-3 Primary opioid days 0-3 
GCS= Glasgow Coma Scale score; LOC= level of consciousness; PRISM III-12 = 
PCPC= Pediatric Cerebral Performance Score; POPC= Pediatric Overall Performance 
Score; 
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Supplement Table 2: Characteristics of the Parent Study Cohort by Group 
Admission Characteristics Total Control Intervention p value 
 n = 2449 n = 1224 n = 1225  
Age at PICU admission, median (IQR),   
years  
1.8 (0.4-
8.2) 
2.6 (0.6-
9.2) 
1.4 (0.3-7.0) 0.002 
Female, No. (%) 1,101 
(45) 
543 (44) 558 (46) 0.53 
Non-Hispanic white, No. (%) 1,233 
(50) 
602/1210 
(50) 
631/1215 (52) 0.81 
Baseline PCPC = 1, No. (%) 1,865 
(76) 
923 (75) 942 (77) 0.41 
Baseline POPC = 1, No. (%) 1,747 
(71) 
862 (70) 885 (72) 0.51 
PRISM III-12 score, median (IQR) 7 (3-13) 8 (5-13.5) 6 (3-11) 0.005 
Primary diagnosis, No. (%) 
     Pneumonia 
     Bronchiolitis 
     Acute respiratory failure related to      
 sepsis 
     Asthma or reactive airway disease 
     Aspiration pneumonia 
     Other 
 
827 (34) 
656 (27) 
357 (15) 
 
207 (8) 
149 (6) 
253 (10) 
 
433 (35) 
228 (19) 
212 (17) 
 
120 (10) 
79 (6) 
152 (12) 
 
394 (32) 
428 (35) 
145 (12) 
 
87 (7) 
70 (6) 
101 (8) 
 
 
 
<0.001 
Past medical history, No. (%) 
     Prematurity 
     Previous exposure to 
 opioids/benzodiazepines 
     Oncology diagnosis 
     Chromosomal abnormality 
 
369 
394 
 
197 (8) 
108 (4) 
 
 
 
 
109 (9) 
48 (4) 
 
 
 
 
88 (7) 
60 (5) 
 
0.37 
 
 
0.31 
0.24 
Weight for age > 95th percentile, No. (%) 307 (13) 144 (12) 163 (13) 0.132 
Pt characteristics  PICU Days 0-3     
Primary opioid agent, No. (%) 
     Morphine 
     Fentanyl 
     Other 
     None 
 
992 (41) 
1,420 
(58) 
13 (<1) 
24 (1) 
 
210 (17) 
989 (81) 
10 (<1) 
15 (1) 
 
 
782 (64) 
431 (35) 
3 (<1) 
9 (<1) 
 
 
<0.001 
     At least one modal SBS score +1/+2, 
No. (%) 
387 (16) 242 (20) 145 (12) 0.002 
     Opioid dose ≥0.2 mg/kg/hour 
 morphine equivalents any day, 
No. (%) 
588 (24) 334 (28) 254 (21) 0.001 
     Benzodiazepine dose ≥0.2 
mg/kg/hour      midazolam equivalents 
any day, No. (%) 
490 (20) 276 (23) 214 (17) 0.002 
     Highest number of secondary 
 sedative agents received any 
day,  median (IQR) 
0 (0-1.0) 0 (0-1.0) 0 (0-1.0) <0.001 
     Unplanned removal of any device, 
No. of   events, (%) 
59 (2) 31 (3) 28 (2) 0.685 
     Inadequate sedation management 
event,  No., (%) 
547 (22) 246 (20) 301 (25) 0.93 
     Received neuromuscular blockade for 
 agitation, No., (%) 
616 (25) 326 (27) 290 (24) 0.66 
     BUN > 20, No., (%) 403 (16) 233 (19) 170 (14) <0.001 
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     ALT > 55, No., (%) 404 (16) 230 (19) 174 (14) <0.001 
ALT= alanine amino transferase; BUN= blood urea nitrogen in mg/dL; IQR= interquartile 
range; PCPC= Pediatric Cerebral Performance Category; POPC= Pediatric Overall 
Performance Category; PRISM III-12= Pediatric Risk of Mortality version III score for first 
12 hours of PICU admission; SBS= State Behavioral Scale score. 
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Supplement Figure 1: CART Variable Importance  
 
BMI= body mass index; BUN= blood urea nitrogen; ISM= inadequate sedation 
management event; No. 3rd agents= number of classes of adjunctive medications 
received; SBS= State Behavioral Scale Score. 
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CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
 Sedation of critically ill children is one of the most commonly provided therapies 
in PICUs, yet clinicians continue to search for the optimal way to provide this therapy.  It 
requires a delicate balance between providing sufficient sedation to ensure the child is 
comfortable and able to tolerate needed interventions such as endotracheal intubation 
and mechanical ventilation, yet not so much that the child is at risk for iatrogenic injury 
and a prolonged length of mechanical ventilation or stay due to oversedation. The 
majority of sedative drugs used in the PICU are used off-label. They have not been 
studied extensively in children, and dosing guidelines are often extrapolated from adult 
studies.(1)  Chapters 1 and 2 of this dissertation describe variability of current practice, 
nationally and internationally, in terms of sedative agents used, methods of assessment 
of the level of sedation, and the use of non-pharmacologic techniques such as noise 
reduction and promoting normal day/night cycling.(2,3)   
PICU patients are a very heterogeneous population and this increases the 
complexity of providing optimal sedation to all patients.  Patients range in age from birth 
to 18 years with a wide variety of diagnoses, and evidence suggests that age and critical 
illness impact the pharmacokinetics and pharmacodynamics of sedation medications. 
(4,5)  Young children do not yet have the developmental skills needed to cognitively 
appraise and understand the PICU environment. In addition, there is recent evidence 
suggesting that sedatives routinely used in the PICU may have a negative impact on 
neurodevelopment in young children.(6,7)  As a result, clinical practice is trending toward 
setting sedation goals of a more awake state, and the decreased use of 
benzodiazepines, with the concomitant increase in the use of other sedative agents. 
These concerns are descriptive of the PICU population as a whole, but there is 
an added level of complexity in providing sedation to patients in the PICU, due to 
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significant inter-patient variability in response to sedation medications.  In particular, 
some children remain consistently agitated despite receiving high doses and multiple 
classes of sedative agents. These children are frequently labeled difficult-to-sedate.  
Studies have acknowledged the existence of this population, but this group has not been 
well described or studied.  This dissertation contributes to the existing knowledge of 
sedation for critically ill children by creating and testing an operational definition of the 
difficult-to-sedate child clinical phenotype, which will be useful in future research. 
Overall Goals 
The purpose of this study was to explore and define the phenomenon of the 
difficult-to-sedate child clinical phenotype within a population of critically ill children. This 
is one of the first studies attempting to operationalize this concept and identify its 
prevalence.  The study had three specific aims: (1) to explore key variables thought to 
be associated with the difficult-to-sedate child and propose a conceptual model linking 
those variables in critically ill pediatric patients; (2) to assess both face and content 
validity of the candidate variables identified in the difficult-to-sedate conceptual model; 
and (3) to build and test a statistical model describing the difficult-to-sedate child clinical 
phenotype.  The conceptual model, described in Chapter 2, served as the foundation for 
the subsequent analyses.  Chapter 3 details the process of establishing face and content 
validity of the variables included in the model, and Chapter 4 details the modeling 
process.  In this exploratory analysis, the majority of variables included in the statistical 
model performed consistently across the two methods of analysis, providing further 
support for the conceptual model. The results of this study show that the difficult-to-
sedate child clinical phenotype is a stable concept, and may represent 18% of the PICU 
patient population.  
Major Findings: Operational Definition 
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 The difficult-to-sedate child is one who requires routine and repeated escalation 
of sedation doses beginning on the first day of intubation, routine administration of 
adjunctive sedation medications over and above the increased opioid and 
benzodiazepine doses, and reaches opioid and benzodiazepine doses above the unit’s 
standard range for the drug within the first three days of intubation without achieving the 
target sedation goal.   
Prior to the definition proposed in this dissertation, no clear operational definition 
of the difficult-to-sedate clinical phenotype existed in the pediatric critical care literature.  
Variability in practice is one of the main reasons for this.  There are several different 
assessment instruments used to identify the child’s level of sedation, many of which lack 
sufficient reliability and validity testing. Some tools, such as the COMFORT B (8) assess 
both pain and agitation, using a single score.  This can be problematic for the clinician at 
the bedside who must use a single score to determine whether pain or anxiety is the 
cause of a child’s distress and then select the appropriate intervention for the child 
receiving both analgesics and opioids.   
Another reason an operational definition is lacking is that routine establishment of 
a daily sedation goal does not occur in most PICUs.  Kudchadkar et al. surveyed an 
international group of pediatric intensivists in 2014 and identified that although 70% of 
units reported using a specific sedation assessment instrument, less than half of those 
units used them regularly to establish a daily sedation goal to guide therapy.(3)  More 
recently, Garcia Guerra et al. (2) surveyed Canadian pediatric critical care intensivists on 
the same topic and found that 74% of PICUs did not routinely identify a daily sedation 
goal.  Without designation of a goal and routine assessment of goal achievement, there 
is no objective way to determine when a child is optimally or sub optimally sedated. 
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 The studies included in the literature review detailed in Chapter 2 consisted of 
seven that assessed the effectiveness of a sedation protocol, 12 that compared two 
different sedation medications or assessed the effectiveness of a single drug and 10 that 
assessed the accuracy of an “objective” sedation measure, most commonly the 
Bispectral index monitor.  All but two of the studies described patients who were 
undersedated, but used a wide variety of metrics.  A frequently used metric was the 
number of observations where a child was above the desired sedation goal.  As detailed 
in Chapter 2, number of episodes of agitation, removal of a patient from study due to 
“treatment failure”, percent of total drug administration time the child was in the target 
sedation range and percent of time a child was undersedated based on a set sedation 
goal were other metrics described.  The variability seen here clearly identifies the lack of 
a consistent operational definition. It is interesting that the studies evaluating drug 
effectiveness and the effectiveness of sedation protocols did not use a consistent metric 
to report the observed rate of undersedation, as this limits the ability to compare 
treatment protocols.  
 The operational definition created through the process of concept analysis 
included several characteristics: routine and repeated escalation of sedation doses 
beginning on the first day of intubation, routine administration of adjunctive sedation 
medications over and above the increased opioid and benzodiazepine doses, and 
reaches opioid and benzodiazepine doses above the unit’s standard range for the drug 
within the first three days of intubation without achieving the target sedation goal.  Young 
age and Trisomy 21 were the two demographic characteristics identified through the 
literature review.  When considering use of this operational definition, it is important to 
note that obtaining sedation scores, setting a sedation score goal, knowledge of the 
standard dose specific to the PICU where the child is receiving care, and knowledge of 
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adjunctive medication are key elements that must be in place.  Utilization of this 
definition across studies in this population will facilitate comparison of results. 
Major Findings: Face and Content Validity of the Operational Definition 
 Chapter 3 describes the process used to establish face and content validity for 
the 17 candidate variables identified through the literature review.  The survey was 
distributed via email to 411 expert pediatric critical care clinicians, primarily physicians, 
from 61 centers across the U.S. The response rate was 29%, and 69% of sites were 
represented. The amount of missing data was minimal, at 0.3%. Respondents scored 
each of the candidate variables using a rating of 1 (not at all relevant) to 4 (highly 
relevant). An item level content validity index (I-CVI) was calculated for each variable, 
and items with an I-CVI≥0.70 were considered important and retained in the model.   
 The participants agreed that the majority of candidate variables proposed were 
characteristic of the difficult-to-sedate child. The 10 variables confirmed for inclusion in 
the final model were as follows: requiring three or more sedation classes simultaneously, 
a daily modal State Behavioral Scale (SBS) score indicating agitation (SBS +1/+2), an 
SBS score indicating agitation for 2 consecutive hours, receiving sedatives at a dose 
>90th percentile of the usual starting dose, receiving intermittent paralytic doses for 
sedation, suspected delirium, unplanned endotracheal extubation, unplanned removal of 
an invasive device, paradoxical response to sedation, and Trisomy 21.  Six items which 
had a low I-CVI were demographic characteristics: not able to verbally communicate, 
>90th percentile for BMI, oncologic diagnosis, moderate or severe cerebral disability, 
moderate or severe overall disability, and bronchiolitis. The highest-rated item was 
requiring three or more sedation classes simultaneously.  Additional characteristics were 
proposed by the respondents, with young age being most consistently cited.  Additional 
variables included in the final model based on expert feedback were medical diagnosis 
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and required multiple sedative agents. In summary, expert clinicians validated that the 
majority of variables extracted from the literature were appropriate to include in the final 
model, along with two additional variables. 
Major Findings: Characteristics of the Difficult-to-sedate Clinical Phenotype 
 Latent Class Analysis (LCA) was used to identify the model which best divided 
the group into clinically meaningful classes.  LCA provides a description of members of 
each class by indicating the probability that they will be positive for any variable.  High 
probability supports inclusion of the variable as class-defining. Evaluation of model fit 
statistics and interpretability identified a two-class model as the best fitting model, with 
classes identified as difficult-to-sedate and not difficult-to-sedate.  Variables which had a 
high probability of being true for the class were identified as characteristic of the difficult-
to-sedate class.  Variables with the highest probabilities and the widest separation from 
the not difficult-to-sedate class included the need for adjunctive medications, less organ 
failure, higher incidence of inadequate sedation events, and normal cognitive state.  The 
not difficult-to-sedate class had a low probability for each of these variables. Repeating 
the analysis using the validation cohort demonstrated that the model was stable across 
the cohorts. The probabilities identified in the testing cohort were found to be similar in 
the validation cohort, with the exception of probability of class membership.  Individuals 
in the testing cohort had a 43% probability of belonging to the difficult-to-sedate class, 
while individuals in the validation cohort had a 19% chance of belonging to the difficult-
to-sedate class.  The characteristics of the difficult-to-sedate class are consistent and 
supported in both cohorts.  The proportion of individuals belonging to the difficult-to-
sedate class were different across the two cohorts, and further testing using different 
sized training and validation cohorts would better define the size of the difficult-to-sedate 
population. 
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Major Findings: Variables Indicating Risk for the Outcome of Difficult-to-sedate 
 CART analysis was used to identify patients at risk of being difficult-to-sedate.  
As detailed in Paper 3 (Chapter 4), CART sorts patients on each of the predictor 
variables included in the model. Unlike LCA, CART requires an outcome variable. Based 
on the literature review and I-CVIs established by the group of critical care experts, a 
composite difficult-to-sedate binary categorical outcome variable was created.  In order 
for a subject to be scored as positive for the outcome,  two criteria had to be met: the 
SBS score had to be +1/+2 and the subjected had to have received at least two times 
the starting dose of an opioid or benzodiazepine continuous infusion on any study day 
from day 0-3.  
The output of a CART analysis includes a decision tree and various fit statistics, 
which are described in detail in Chapter 4. Variables which identified a patient as at risk 
for being difficult to sedate included need for adjunctive sedation medications, daily 
modal SBS score of +1/+2, occurrence of an inadequate sedation management event, 
presence of an elevated blood urea nitrogen  (BUN) level, age, weight, and race.    
Sensitivity and specificity are important indicators of a useful decision tree, as 
they indicate whether a subject was placed into the appropriate category.   Each of the 
analyses demonstrated good specificity, correctly identifying difficult-to-sedate patients 
94% of the time.  However sensitivity was low, resulting in patients being classified as 
difficult-to-sedate when in fact they were not positive for any of the indicator variables. 
Major Findings: Characteristics Identifying the Difficult-to-sedate Clinical 
Phenotype 
Regardless of the methodology used, some characteristics were important 
indicators of this group, and aligned with expert opinion.  The requirement for adjunctive 
medications, presence of organ failure, particularly renal failure, occurrences of 
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inadequate sedation management events, high daily modal SBS scores and need for 
vasoactive medications were sorting characteristics in both CART and LCA.  CART also 
identified young age and primary diagnosis as important predictor variables, which align 
with our conceptual model and the opinion of experts.  The results of these analyses 
provide support for the operational definition proposed in Paper 1. Approximately 18% of 
patients demonstrated the difficult-to-sedate outcome, based on the operational 
definition of difficult-to-sedate.  This is one of the first studies attempting to determine the 
incidence of this clinical phenotype. Although it is difficult to extrapolate an expected rate 
of incidence from the literature reviewed, our finding does not seem excessively high.   
Limitations 
 This study was a secondary analysis of an existing data set, and it is likely that 
characteristics important to our concept were not included or available in the RESTORE 
data set.  Missing data had an impact on the data analysis.  Sedation assessment was a 
key variable, and 9% of subjects were missing SBS scores on all days. Because SBS 
scores contributed to the composite outcome variable created for the CART analysis, 
subjects who did not have SBS scores recorded on days 0 - 3 could not be included in 
the CART analysis.  As a result, the incidence of the difficult-to-sedate clinical phenotype 
reported here might have been mis-estimated.  It is important to note that overall, the 
data from RESTORE was of high quality, as sites routinely assessed inter-rater reliability 
for the SBS score and demonstrated high reliability.  
 A major assumption of this study was that pain was adequately controlled in this 
population.  It is possible that this was not the case, especially early in the patient’s 
course of treatment which was the timeframe evaluated in this study.  The patients 
enrolled in RESTORE primarily had medical diagnoses, as opposed to surgical 
diagnoses, so it is less likely that pain was a highly significant issue for this group.  
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However, because patients did have medical diagnoses, the generalizability of our 
findings is limited. 
Achieving optimal sedation is a very complex process, involving more than the 
child’s clinical phenotype.  The conceptual model described in Paper 1 indicates that in 
addition to child specific factors, process and environmental factors also influence 
sedation outcomes.  This study focused exclusively on patient level factors in describing 
the difficult-to-sedate clinical phenotype, which is a simplistic approach given that 
phenotype is a set of observable characteristics created through the interaction of the 
individual’s genotype with the environment.  In future studies, it will be important to 
evaluate the impact of environmental and process factors. 
 Finally, this exploratory study employed a very straightforward approach to 
machine learning techniques. Testing a more complex model using covariates might 
help to refine the model and improve sensitivity.   
Directions for Future Research 
 The majority of critically ill children in PICUs require mechanical ventilation, and 
therefore receive sedation.  Establishing the clinical phenotype of the difficult-to-sedate 
child and its incidence in a cohort of children supports the necessity for continued work 
in this area, as there are physiologic, developmental, psychosocial and economic 
impacts resulting from undersedation.  This study raises many new questions and 
suggests multiple areas for investigation. 
 It is necessary to replicate the findings from this study prospectively in other 
populations.  For example, this study identified the incidence of the difficult-to-sedate 
child clinical phenotype as approximately 13%. It will be important to examine this 
statistic in other patient populations, in order to determine the true incidence.  It will also 
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be important to validate the characteristics and risk factors described in this study in 
other cohorts of critically ill children.   
 The characteristics included in this model were theoretically determined and then 
validated through a survey of practicing PICU clinicians, primarily physicians, prior to 
testing.  Nurses are also intricately involved in providing sedation to critically ill children 
and monitoring the outcome.  It would be useful to explore this model with nurses 
experienced in providing sedation to critically ill children, in order to continue to develop 
and refine the model. 
 An important area for future investigation is exploring a genetic basis for this 
phenotype. Phenotypes are observed characteristics of the individual that result from the 
interaction of the genotype, the environment, and other factors.  Clinical phenotypes are 
useful specifically because they are observable. Examining the genomes of a group of 
individuals presenting with a particular observed trait such as an unexpected response 
to sedation increases the likelihood that a genome-wide association study (GWAS) could 
identify genetic variants that contribute to the altered drug response. A well-defined 
phenotype that clearly identifies affected individuals enhances the effectiveness of a 
well-designed GWAS.   
Examining the genomes of phenotypic individuals through a GWAS has been 
used successfully to identify specific families of genes in the cytochrome P450 enzyme 
system, which characterize individuals in terms of their metabolism of codeine and other 
pain and sedation medications (9).  Genetic polymorphisms cause intra-individual 
variation in enzyme activity, resulting in varying rates of drug metabolism, expressed as 
different phenotypes.  Two groups of particular concern have been labeled poor 
metabolizers and ultra-rapid metabolizers as those individuals do not process drug in the 
“typical” way and are at risk for adverse drug reactions.  Commercially available assays 
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that test for these specific polymorphisms exist and are becoming more affordable, and 
as a result are beginning to be utilized in clinical practice.(10).   
The CYP3A4 enzyme, part of the cytochrome P450 enzyme system has been 
linked to the action of midazolam and other benzodiazepines.(11) Identifying the 
particular genetic variant responsible for differing action in different individuals would 
support clinical care in a variety of ways.  Clinicians currently base initial drug dosing of 
sedatives on a standard dose known to be effective for the majority of patients and 
adjust the dose as needed based on the patient’s response. Multiple dose adjustments 
over an extended period may be required to achieve the target sedation level in a patient 
with an atypical response. The undersedated child remains at risk for iatrogenic injury 
until the correct drug and dose are identified.  Knowledge of the patient’s genotype 
specific response to sedation medications would allow individualization of both the drug 
selected and the appropriate dose. In addition to quickly achieving the desired sedation 
level, the patient would not be exposed to drugs known to be ineffective for their 
genotype.  This is particularly important in light of the current concern related to 
neurotoxic effects of sedatives on the developing brain.(12,13) 
Conclusion 
 The three papers developed in this dissertation study explored the concept of the 
difficult-to-sedate child clinical phenotype and accomplished three objectives.  A 
comprehensive review of the literature identified the lack of an operational definition and 
facilitated extraction of possible factors contributing to the clinical phenotype.  These 
factors were used to provide an initial operational definition and construct a conceptual 
model. A panel of expert critical care clinicians validated the elements of the operational 
definition through an assessment of face and content validity and proposed additional 
factors to be included in the model. A refined definition was tested using data from the 
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RESTORE study.  The characteristics identified through latent class analysis were 
similar to risk factors identified through classification and regression tree analysis, and 
consistent with the conceptual model proposed.   
Decreasing the ambiguity that currently exists around the concept of the difficult-
to-sedate child clinical phenotype is a major achievement of this study.  A clear 
operational definition of the concept promotes its consistent measurement and facilitates 
future investigation. This definition can be utilized by other researchers, allowing useful 
comparisons across studies.  The conceptual model and operational definition 
developed in this study require further investigation and refinement, as well as validation 
by other investigators.  This study suggests that a clinically meaningful population of 
difficult-to-sedate children requiring mechanical ventilation for a critical illness exists.  
Documentation of this phenotype promotes the development of evidence on the best 
way to support these children. Critically ill difficult-to-sedate children and their families 
will benefit from future research exploring this question. 
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